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ABSTRACT

Peroxisomes are organelles whose roles in fatty acid metabolism and
reactive oxygen species (ROS) elimination have contributed much attention in
understanding their origin and biogenesis. Many studies have shown that de novo
peroxisome biogenesis is an important regulatory process, while yeast studies
suggest that total peroxisome numbers are in part regulated by proteins such as
Pex11, which can facilitate the division of existing peroxisomes. Although de
novo biogenesis and divisions are likely important mechanisms to peroxisome
functioning, the regulation of peroxisome numbers during embryonic development
is poorly understood. Peroxisome number and function are particularly crucial in
oviparous animals such as frogs where large embryonic yolk and fatty acid stores
must be quickly metabolized, and ROS eliminated.

The central role of

peroxisomes with respect to ROS is in the generation and scavenging of hydrogen
peroxide.

Recent studies have revealed their involvement in metabolism of

oxygen free radicals that have important functions in cell signaling.

Using

Xenopus laevis as a developmental model, this study demonstrates that
overexpression and inhibition of Pex11β directly increases and decreases
peroxisome number in vitro, and induces an early- or delayed-onset to peroxisome
biogenesis in vivo, respectively. Knockdown of Pex11β, decreasing peroxisome
numbers, induced a bent/double-axis phenotype compared to that of control
uninjected embryos. This phenotype has previously been linked to increases in the

iii

redox sensitive-noncanonical Wnt/Planar Cell Polarity (PCP) cell signaling. As a
result, this study investigated if changes in peroxisome number could affect
intracellular ROS levels, thereby activating redox-sensitive cell signaling
pathways such as canonical and noncanonical Wnt signaling. Following inhibition
of Pex11β, there were significant increases in ROS levels in X. laevis A6 cells. I
show for the very first time that changes in cellular ROS levels, as a result of
decreases in peroxisome numbers, perturb noncanonical Wnt cell signaling.
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GLOBAL INTRODUCTION AND LITERATURE REVIEW
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1.1 Peroxisomes
The myriad of complex functions that are performed by multicellular organisms
are carried out by individual cells.

Cells in part coordinate their various activities

through the presence or regulation of specialized or ubiquitous organelles, which thereby
regulate metabolic activities, remove waste, and allow for cell communication and cell
migration. Such is the case with peroxisomes, small ubiquitous organelles whose role in
lipid metabolism belies their complexity.

1.1.1 Peroxisome overview
Peroxisomes

are

single

membrane-bound

subcellular

organelles

found

ubiquitously in virtually all eukaryotic cells. They were first identified by Dr. Christian
Du Duve in 1966 as spherical or ovoid cellular structures, ranging in sizes from 0.1 to 1.5
μm in diameter, and containing a fine granular matrix (De Duve and Baudhuin 1966).
On average, cells contain roughly 400 peroxisomes occupying 2% of total cell volume.
The single membrane of peroxisomes is quite unlike that of other organelles in terms of
its permeability properties, mainly because it is more permeable to small molecules such
as sucrose and inorganic ions.

These unique membrane properties impart onto

peroxisomes attributes that are key to their function.
Peroxisomes fulfill a variety of important roles that are essential for normal cells
to maintain physiological functions, such as the metabolism of lipids and reactive oxygen
(ROS), which are described below. Such vital activities render these organelles essential
to the cell, and therefore to overall organismal health. In addition to these ubiquitous
activities, peroxisomes have taken on several specialized functions unique to different

	
  

3

species including; glycolysis in protozoa; penicillin biosynthesis in fungi; plasmalogen
biosynthesis in mammals, and photorespiration and the glyoxylate cycle in plants
(Kurbatova, Dutova et al. 2005). Of particular importance, is the role of peroxisomes in
the regulation of ROS. Consequently, they house multiple oxidative and non-oxidative
enzymes involved the production and scavenging of ROS, such as catalase, superoxide
dismutases (SOD) 1, peroxiredoxin (Prdx) 5, glutathione peroxidase (Gpx) and
glutathione (GSH).

Their complex antioxidant defense system has identified these

organelles as a primary source of oxidative stress, aging and neurodegeneration when
they become non-functional, or their numbers are aberrant (Kregel and Zhang 2007).
One of the more intriguing aspects of peroxisomes is how cells control the
number of these organelles. Eukaryotic cells contain hundreds of peroxisomes under
normal cellular conditions, but this number is typically in flux, suggesting there are
mechanisms for regulating total peroxisome number. These numbers may change in
response to metabolic demands, oxidative stress and extracellular stimuli, indicating the
existence of signal transduction pathways that exert additional control over peroxisome
numbers (Li and Gould 2002).

1.1.2 Peroxisome proliferator activator receptors (PPARs)
Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear
membrane receptors that behave as transcription factors and which upon activation
control a variety of cellular and metabolic processes. PPARs were first identified in
Xenopus laevis, as receptors capable of inducing peroxisome proliferation. PPARs are
ligand-activated transcription factors and exist as three isoforms – PPARα, -β/δ and –γ,
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all of which have been identified in vertebrates. Upon activation of PPARs, respective
receptors form heterotypic dimers with retinoid-X-receptors (RXR) while binding to
peroxisome proliferator response elements (PPRE) inducing transcription of genes
associated with diverse cellular function (Figure 1.1).

The biological functions of

PPARα, -β/δ and -δ are distinct, yet all three PPARs individually affect inflammation
and homeostasis (Goto, Lee et al. 2011). PPARα is primarily involved in regulating
peroxisome proliferation and fatty acid metabolism via transcriptional activation of genes
encoding key enzymes involved in metabolism (Finck 2007). PPARβ/δ can trigger
adipocyte differentiation by inducing the expression of multiple genes involved in
adipogenesis (Goto, Lee et al. 2011). Lastly, PPARδ has received much attention for its
ability to regulate fatty acid storage and glucose metabolism, and its relationship to
peroxisome number (Goto, Lee et al. 2011). The regulation of PPARs is complex,
involving numerous potential ligands that regulate multiple genes (Alvarez-Guardia,
Palomer et al. 2011). Overall, PPARs play essential roles in the regulation of cellular
differentiation, development, metabolism, tumorigenesis, the number and overall function
of peroxisomes and in the regulation of a family of proteins involved in peroxisomes
functioning termed peroxisome biogenesis factors.
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Figure 1.1. Peroxisome proliferator-activated receptors (PPARs). PPARs are a group
of nuclear receptor proteins that function as transcription factors regulating the
expression of a wide-variety of genes. PPARs play essential roles in the regulation of
cellular differentiation, development and metabolism, peroxisome biogenesis and
tumorigenesis. All PPARs heterodimerize with the retinoid X receptor (RXR) and bind
to specific regions of DNA sequences termed peroxisome proliferator hormone response
elements (PPREs).
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1.1.3 Peroxisome biogenesis factors (Pex)
Both peroxisome biogenesis and the regulation of peroxisome number are
achieved through the coordinated activity of a family of proteins termed peroxins.
Peroxins are nuclear-encoded Pex genes, synthesized on free polyribosomes in the
cytosol and post-translationally imported into the organelle (Table 1). Peroxins are found
localized in the cytosol, the membrane and the matrix of peroxisomes, and the latter can
be imported into the peroxisome matrix in a folded and/or even oligomeric form
(Erdmann and Schliebs 2005). Peroxins are essential for function of peroxisomes, and
the loss of function of various peroxins abrogates peroxisome formation. Such loss of
function conditions are linked to a variety of human diseases termed peroxisome
biogenesis disorders (PBD). Consequently, symptoms of these diseases often occur as a
result of improper fatty acid metabolism.
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Table 1. List of molecular mechanisms and functions of peroxisome biogenesis factors.
GENE
Pex1
Pex2
Pex3
Pex4
Pex5
Pex6
Pex7
Pex8
Pex9

CHARACTERISTICS

BIOGENESIS
FUNCTION
AAA-type ATPase
Matrix protein
import
RING-finger
Matrix protein
import
N/A
PMP-targeting; de
novo formation
Ubc
Matrix protein
import
WxxxF-motifs; TPR Matrix protein
region, ubiquitinated
import
AAA-type ATPase
Matrix protein
import
WD40 motif
Matrix protein
import
Coiled-coil domain; Matrix protein
leu-zipper
import
N/A
Matrix protein
import

Pex10 RING-finger
Pex11 N/A
Pex12 RING-finger
Pex13 SH3-domain
Pex14 PXXP-motif;
phosphorylated
Pex15 Phosphorylated
Pex16 N/A
Pex17 N/A
Pex18 WxxxF-motifs;
ubiquitinated
Pex19 CAAX-box;
farnesylated
Pex20 WxxxF-motifs;
ubiquitinated
Pex21 WxxxF-motifs;

Matrix protein
import
Proliferation
Matrix protein
import
Matrix protein
import
Matrix protein
import
Matrix protein
import
PMP-targeting;
proliferation;
de
novo formation
Matrix protein
import
Matrix protein
import
PMP-targeting; de
novo formation
Matrix protein
import
Matrix protein

MOLECULAR MECHANISM
ATPdependent dislocation of Pex5p
N/A
Membrane anchor of Pex19p
Mono-ubiquitination of Pex5p
PTS1-receptor
ATPdependent dislocation of Pex5p
PTS2-receptor
Connection of docking- and
RING-complex; cargo release (?)
ORF
of YlPEX9
was
misidentified;
corresponds
to HsPEX26
N/A
Elongation of peroxisomes
N/A
Member of the docking complex
Member of the docking complex
Membrane anchor of Pex6p
N/A
Member of the docking complex
PTS2-co-receptor in Sc
PMP-class
I
receptor
and
chaperone
PTS2-co-receptor in most fungi
PTS2-co-receptor in Sc
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ubiquitinated (?)
Pex22 N/A
Pex23
Pex24
Pex25
Pex26

DysF
N/A
N/A
N/A

Pex27
Pex28
Pex29
Pex30
Pex31
Pex32

N/A
N/A
N/A
DysF
DysF
DysF

import
Matrix protein
import
Proliferation
Proliferation
Proliferation
Matrix protein
import
Proliferation
Proliferation
Proliferation
Proliferation
Proliferation
Proliferation

Membrane anchor of Pex4p
Growth regulation in Yl
Separation of peroxisomes in Yl
Elongation of peroxisomes
Membrane anchor of Pex6p in Hs
Elongation of peroxisomes
Separation of peroxisomes in Sc
Separation of peroxisomes in Sc
Growth regulation in Sc
Growth regulation in Sc
Growth regulation in Sc
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1.2 Physiological Functions of Peroxisomes
1.2.1 Fatty acid β-oxidation
Peroxisomes are the primary site of β-oxidation of very long chain (VLCFA) and
long chain (LCFA) fatty acids (Mannaerts and van Veldhoven 1996). The byproducts of
β-oxidation in the mitochondrion are fed into the Krebs cycle and electron transport
chain to generate ATP, whereas β-oxidation in peroxisomes is not directly coupled to an
energy generating system. Instead, it is believed acetyl-CoA, a byproduct of β-oxidation,
is utilized as an entry molecule for the Krebs cycle (Mannaerts and van Veldhoven 1996).
Studies have indicated that β-oxidation levels appear to be involved in regulating
peroxisome number.

For instance, human fibroblast cells deficient in β-oxidation

enzymes derived from patients with Zellweger Syndrome (ZS), a PBD, show a decreased
number of peroxisomes (Chang, South et al. 1999).

In addition to peroxisomal β-

oxidation, the compartmentalization of this reaction to peroxisomes may serve to protect
cells from high levels of oxidative damage. Repeated β-oxidation events result in the
generation of high levels of ROS, which are quickly eradicated by enzymes within the
peroxisome, protecting the rest of the cell from these deleterious byproducts.

1.2.2 Peroxisomes and reactive oxygen species (ROS)
Oxygen is consumed in various metabolic reactions in different cellular locations,
such as mitochondria, endoplasmic reticulum (ER), and peroxisomes.

Unlike

mitochondria, β-oxidation in peroxisomes is not coupled to oxidative phosphorylation,
and does not lead to the production of ATP. Rather, the high potential electrons are
removed from various metabolites to reduce molecular oxygen, yielding hydrogen
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peroxide (H2O2), superoxide anion (O2·−) and the hydroxyl radical (·OH) (Antonenkov,
Grunau et al. 2010). This supports the notion that peroxisomes play a key role in both the
production and subsequent scavenging of ROS.

The main physiological function of

peroxisomes was at first assumed to be the decomposition of H2O2 into water and oxygen
via catalase – a prototypical peroxisomal enzyme and marker. However, peroxisomes are
involved in a variety of other ROS-related functions. Studies have estimated that about
40% of all H2O2 formed in rat liver is derived from peroxisomal oxidases (Boveris,
Oshino et al. 1972). To regulate ROS produced in peroxisomes and to maintain the
equilibrium between production and scavenging of ROS, peroxisomes harbor multiple
antioxidant enzymes in addition to catalase. The detailed mechanisms of ROS
metabolism are discussed further in Section 1.8.

1.2.3 Plasmalogen biosynthesis
Plasmalogen is a type of ether-phospholipid that is synthesized in peroxisomes
and comprises an estimated 18% of the total phospholipids in mammals (Wanders and
Waterham 2006). Plasmalogens are found in numerous human tissues, particularly in the
nervous, immune, and cardiovascular systems. In human heart tissue, nearly 30-40% of
phospholipids are plasmalogens. Similarly, almost 30% of the phospholipids in the adult
human brain are plasmalogens, which compose up to 70% of the myelin sheath (Gorgas,
Teigler et al. 2006).

Consequently, the absence of plasmalogens results in

irregularities in the myelination of nerve cells (along with other physiological defects),
and is a large factor that is related to PBDs and their link to severe neurological
abnormalities. Plasmalogen biosynthesis was first linked to peroxisomes following the
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observations that infants suffering from Zellweger Syndrome displayed severe
deficiencies in plasmalogen, caused by defects in peroxisome biogenesis. Although the
functions of plasmalogens have not been elucidated, they have been linked to modulators
of membrane dynamics (Nagan and Zoeller 2001).

1.3 Peroxisomal matrix protein biogenesis and insertion
1.3.1 Peroxisomal targeting signals and their receptors
Since peroxisomes do not contain DNA, all of their matrix and membrane
proteins are nuclear-encoded and synthesized on polyribosomes in the cytosol.
Peroxisomal matrix proteins are targeted to the peroxisomal lumen by two distinct
peroxisomal targeting signals, PTS1 and PTS2.
PTS1 is a C-terminal tripeptide sequence, serine-lysine-leucine (SKL) and is
found on the majority of matrix proteins, while its derivative, lysine-alanine-asparagineleucine (KANL) is found on distinct peroxisomal matrix proteins such as catalase
(Legakis, Koepke et al. 2002). The cytosolic molecular receptor, Pex5, is responsible for
the recognition of posttranslational PTS1-containing proteins destined for the
peroxisomal matrix. Pex5 contains a highly conserved C-terminal domain, composed of
5-7 tetratricopeptide (TPR) motifs (Williams, Schueller et al. 2011). These TPR domains
interact with PTS1 on respective peroxisomal proteins. The Pex5 TPR domains undergo
conformational changes, switching from an open to closed conformation following
receptor-cargo binding and release, respectively. (Stanley and Wilmanns 2006). The Nterminus of Pex5 is less conserved and interacts with peroxins such as Pex8, Pex13 and
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Pex14, which are involved in receptor-cargo docking on the peroxisomal membrane
during cargo translocation.

However, the extreme N-terminus is essential for Pex5

recycling following matrix protein import, a process that is dependent on either the
mono- or polyubiquitination of Pex5, as described in section 1.3.4.
PTS2 is a nona-peptide sequence, R/K-L/V/I/Q-X2-L/V/I/H/Q-L/S/G/A/K-X-H/QL/A/F, found near the N-terminus of a smaller subset of peroxisomal matrix proteins
(Petriv, Tang et al. 2004).

PTS2 is a less common targeting sequence. Import

mechanisms associated with PTS2 are far less understood, but believed to follow a
similar pathway as Pex5-PTS1 type cargoes. Delivery of PTS2 proteins to peroxisomes
requires the cooperation of the PTS2 cytosolic molecular receptor Pex7.

1.3.2 The peroxisomal importomer
Following binding of peroxisomal proteins to their cytosolic receptors, delivery
into the matrix is accomplished by a peroxisomal membrane bound protein complex
called the importomer. The importomer is a diverse set of protein complexes located in
the peroxisomal membrane that partake in protein translocation and the recycling, or
degradation of cytosolic receptors. The importomer is made of two distinct protein
complexes, which are bridged by other peroxins.
The first protein subcomplex, made of Pex13, multiple (≥ 2) Pex14s and Pex17, is
classified as a docking station for receptors (Figure 1.2) (Rayapuram and Subramani
2006).

Pex13 is believed to have a higher affinity for cytosolic receptor-cargo

complexes, initiating receptor-cargo docking, while Pex14, is believed to mediate protein
translocation into the peroxisomal matrix (Figure 1.2). The second protein subcomplex is
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made of three individual ubiquitin ligase E3-like proteins, Pex2, Pex10 and Pex12
(Figure 1.2). These individual proteins contain really interesting new genes (RING)
finder domains (Peraza-Reyes, Arnaise et al. 2011), a protein structural domain of the
zinc finger type, that mediate PTS receptor recycling and/or degradation.

The

importomer also includes individual proteins, such as Pex8 and Pex3, which bridge the
docking and RING subcomplexes to one another (Figure 1.2) (Meinecke, Cizmowski et
al. 2010).
The importomer is also associated with receptor recycling machinery, which is
responsible for tagging receptors either for recycling back to the cytosol for additional
rounds of cargo import, or degradation. The recycling machinery consists of Pex4, a
homologue of E2 ubiquitin conjugating enzyme, which is anchored to the importer by
Pex22, and Pex1 and Pex6, and two ATPases associated with diverse cellular activities
(AAA-ATPases), which are anchored to the importomer by Pex15 and Pex26 (Figure 1.1)
(Rosenkranz, Birschmann et al. 2006). Through a series of coordinated interactions,
receptors deliver their respective cargos to the importomer and are continuously shuttled
back to the cytosol for subsequent rounds of import by the receptor-recycling machinery,
unless otherwise targeted for degradation (Figure 1.2 versus 1.3). These processes must
be tightly regulated to achieve normal peroxisome function. Indeed, recent mammalian
studies have shown that a lack of any components of the importomer is characterized by
the cytosolic mislocalization of peroxisomal matrix proteins (Purdue and Lazarow 2001).
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Figure 1.2. Peroxisomal matrix protein import and receptor recycling pathway.
Peroxisomal matrix protein import is divided into six distinct steps. (1) Receptor-cargo
binding in the cytosol. Cytosolic receptors recognize PTS containing cargo in the cytosol
and are transported to the peroxisomal importomer.

(2) Receptor-cargo docking.

Receptor-cargo complexes dock on the cytoplasmic face of the peroxisome membrane at
the importomer docking station made of Pex17, Pex14 and Pex13. This docking station
is proposed to be involved in tethering the receptor to the membrane. (3) Translocation of
the receptor-cargo complex. Pex2, Pex10 and Pex12 form a RING finger complex,
which work in conjunction with Pex8 to translocate the respective cargo into the
peroxisomal matrix. (4) Monoubiquitination and (5) dislocation of the receptor.
Monoubiquitination is mediated by the E2-enzyme Pex4, which is membrane-anchored
by Pex22. The release of the receptor requires AAA-ATPases Pex1 and Pex6, in an ATP
dependent manner, following which (6) the receptor is recycled into the cytosol for
additional rounds of matrix protein import.
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1.3.3 Cargo translocation into the peroxisomal matrix
The

mechanism

regarding

translocation

of

different

proteins

across

the peroxisomal membrane and release of cargo into the matrix remains largely unknown,
particularly as large, folded, even oligomeric proteins can cross the peroxisomal
membrane. One hypothesis with respect to protein translocation into the matrix involves
the receptor Pex5, which is believed to alter peroxisomal membrane topology during
the protein import cascade (Nair, Purdue et al. 2004). Although it seems clear that the
receptor–cargo complex reaches the luminal side of the membrane, it is still unknown
whether only part of Pex5 extends into the lumen, referred to as the shuttle hypothesis, or
whether the whole receptor enters the matrix, known as the extended shuttle hypothesis.
Following these membrane-associated events, cargo is released and Pex5 is translocated
back to the cytosol, where respective cargo is translocated into the peroxisomal lumen.

1.3.4 Cargo release
Various hypotheses have described the mechanism whereby matrix proteins are
dissociated from their receptors and released into the peroxisomal lumen, however, these
theories remain unverified. One model predicts that a pH gradient is responsible for
receptor-cargo dissociation, resulting in cargo release in the peroxisomal matrix.
Acidification of the cytosolic face of the importomer via hydrogen pumps is hypothesized
to mediate this process (Meinecke, Cizmowski et al. 2010). This model is based on
previous findings in yeast, which predicts the oligomeric states of Pex5 can switch from a
cargo-bound tetramer at neutral pH (7.2) to a cargo-free monomer at acidic pH (6.0)
(Wang, Visser et al. 2003)
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Another component of the importomer, Pex13, was found to have a higher affinity

for cargo-free receptors, relative to cargo-bound receptors. Therefore, other hypotheses
for cargo release have been proposed that highlight the interactions between the Nterminal region of Pex5 with the docking station of the importomer – Pex14, Pex13 and
Pex17 (Platta and Erdmann 2007). These protein interactions could have an effect on the
conformation of the TPR domain on Pex5, which may switch from a closed conformation
back to an open conformation, resulting in cargo release (Stanley and Wilmanns 2006).
However, much of this theory remains speculative and requires further investigation.

1.3.5 PTS receptor recycling and the RADAR pathway
Following cargo translocation and release, cargo-free receptors either shuttle back
to the cytosol for additional rounds of protein import, or are degraded via the proteasome
– a process referred to as the receptor accumulation and degradation in the absence of
recycling (RADAR) pathway (Leon and Subramani 2007) (Figure 1.3). Once cargo is
released into the peroxisomal matrix, cytosolic receptors are modified by either
monoubiquitination, the linkage of a single ubiquitin molecule, or polyubiquitination, the
conjugation of at least four ubiquitin molecules. Mono- and polyubiquitination serve as
signals for receptor recycling or proteasomal degradation via RADAR, respectively
(Purdue and Lazarow 2001; Platta and Erdmann 2007).

Both processes require a

ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and ubiquitin
ligase (E3) to conjugate ubiquitin to cytosolic receptors (Kerscher, Felberbaum et al.
2006).

Current opinion is that the RADAR pathway is utilized only under certain
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physiological conditions such as the occurrence of dysfunctions in cytosolic receptors
(Ma, Agrawal et al. 2011).
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Figure 1.3. Peroxisomal matrix protein import and RADAR pathway. Peroxisomal
matrix protein import is divided into six distinct steps. (1) Receptor-cargo binding in the
cytosol. Cytosolic receptors, such as Pex5, recognize PTS containing cargo in the cytosol
and are transported to the peroxisomal importomer.

2) Receptor-cargo docking.

Receptor-cargo complexes dock on the cytoplasmic face of the peroxisome membrane at
the importomer docking station consisting of Pex17, Pex14 and Pex13. This docking
station is proposed to be involved in tethering the receptor to the membrane. (3)
Translocation of the receptor-cargo complex. Pex2, Pex10 and Pex12 form a RING
finger complex, which works in conjunction with Pex8 to translocate the respective cargo
into the peroxisomal matrix. (4) Polyubiquitination and (5) dislocation of the receptor.
Polyubiquitination is mediated by enzymes Ubc5, Ubc4 and Ubc1, and occurs at the
peroxisomal membrane. The release of the receptor requires AAA-ATPases Pex1 and
Pex6, in an ATP dependent manner. (6) Receptor degradation via the proteasome.
Numbers on diagram represent individual peroxins.
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1.4 Peroxisomal membrane protein biogenesis and insertion
1.4.1 The role of mPTS in PMP Biogenesis
As with peroxisomal matrix proteins, peroxisomal membrane proteins (PMPs) are
encoded in the nucleus and must be imported into the peroxisome membrane or ER posttranslationally. The insertion of PMPs is accomplished by two distinct sorting pathways;
Class I and II. Class I PMPs are synthesized on free ribosomes in the cytosol and are
subsequently imported into the peroxisomal membrane (Figure 1.4). Insertion depends
on internal membrane targeting sequences (mPTS) and requires the peroxins Pex19
and Pex3, and in some organisms Pex16 (Platta and Erdmann 2007). Deletion of either
of these proteins results in the absence of detectable peroxisomal membrane structures. It
is believed that Pex3 is a membrane recruitment factor for cargo-loaded Pex19 (Fang,
Morrell et al. 2004).

Pex19 can shuttle between the cytosol and the peroxisomal

membrane, ferrying newly synthesized PMPs in a stable conformation for membrane
insertion (Jones, Morrell et al. 2004). The functional role of Pex16 is less clear, however
it has been suggested that it may function as a tethering factor for Pex3, or as a
component of the membrane-insertion machinery for PMPs. In addition to a membrane
anchoring sequence, class I PMPs exhibit conserved Pex19-binding sites, which are also
required for their membrane import and stability (Vizeacoumar, Vreden et al. 2006).
Conversely, the second PMP sorting pathway (Class II) is independent of the functions
of Pex19, Pex3 and Pex16, and in fact it is Pex3 and Pex16 alone that are believed to
represent Class II PMPs (Fang, Morrell et al. 2004). Unlike class I PMPs, these proteins
are not targeted directly to peroxisomes, but instead appear to be sorted to the peroxisome
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via the ER (Figure 1.4) (Hoepfner, Schildknegt et al. 2005) a process, which is discussed
further in section 1.4.2.
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Figure 1.4. Import of Class I and Class II PMPs. Class I PMPs contain a Pex19
binding site, a membrane anchor sequence and an mPTS sequence. These PMPs are
synthesized on polysomes and recognized by Pex19, which ferries proteins from the
cytosol to the peroxisomal membrane via docking to Pex3 at the membrane. Class II
PMPs are targeted to the ER and are believed to behave as membrane recruitment factors
in the de novo biogenesis of peroxisomes.
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1.4.2 Trafficking of Class II PMPs through the ER
The notion that class II PMPs are trafficked to the peroxisome through the ER is
supported by findings that show certain PMPs contain ER-specific modifications. For
instance, the integral PMPs Pex2 and Pex16 are N- or O-glycosylated, and the tail
anchored peroxin, Pex15, is O-mannosylated (Elgersma, Kwast et al. 1997; Titorenko
and Rachubinski 1998).
Furthermore, pulse-chase experiments in mutant yeast lacking functional
peroxisomes showed the reappearance of peroxisomes following complementation
analyses with Pex3 and Pex19 (Hoepfner, Schildknegt et al. 2005).

Pex3 was

fluorescently labeled and detected as punctate-like structures in the ER (Fang, Morrell et
al. 2004). These structures were found to bud from the ER in a Pex19-dependent fashion,
indicating Pex3 and Pex19 are both necessary and sufficient to mediate peroxisomal
vesicle budding from the ER. These data suggest that the ER is a membrane template for
de novo peroxisome biogenesis, and as such, it is referred to as the preperoxisomal
reticulum (Figure 1.5). As many of the steps involved in the formation of peroxisomes
are still being elucidated, there also remains a lack of understanding regarding the
parameters that regulate the number and size of peroxisomes found in a cell.
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Figure 1.5. Peroxisome de novo biogenesis. Peroxins are synthesized on free
polyribosomes in the cytosol and sent to the endoplasmic reticulum (ER) or directly into
functional organelles. The de novo biogenesis pathway suggests that peroxins, such as
Pex3 – an intrinsic membrane protein, enters the ER through the Get1 translocon, and can
bud from the ER, utilizing the ER-membrane as a template for de novo biogenesis
referred to as the preperoxisomal reticulum. With the assistance of Pex19, a molecular
chaperone, Pex3 can bud from the ER. Following the formation of preperoxisomes, the
organelles themselves can mature via fusion of adjacent organelles or via
membrane/matrix protein import.
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1.5 Pexophagy
A variety of cellular and physiological responses partake in governing the number
of peroxisomes at any given time. Peroxisomes can change in number by a selective
degradation autophagy-related process termed pexophagy. Knowledge of these processes
remains limited, however, in recent years the molecular mechanisms are starting to
unfold. Pexophagy is a complex process, involving over 30 different proteins in addition
to a variety of autophagy related genes (ATGs).

Two basic models for selective

peroxisome degradation have been described termed macro- and micropexophagy.

1.5.1

Macropexophagy
The selectivity of macropexophagy is such that it is strictly related to mature

organelles. It is believed that Pex3, an integral membrane protein involved in PMP
import machinery, is removed from the peroxisomal membrane, polyubiquitinated and
degraded via the proteasome – a process required to initiate macropexophagy (Bellu,
Salomons et al. 2002). Pex14, part of the importomer involved in protein docking,
functions similarly in macropexophagy as it is required for the docking of ATG11, which
initiates the formation of a sequestration membrane (SM). Formation of the SM produces
a double membrane pexophagosome (PP), which will fuse with adjacent vacuoles,
resulting in eventual degradation by hydrolases (Figure 1.6).

1.5.2. Micropexophagy
The process of micropexophagy requires the function of several proteins involved
in macropexophagy and other autophagic pathways. Vacuolar membranes first develop
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protrusions adjacent to the surface of target peroxisomes and engulf them sequentially
(Farre and Subramani 2004). ATG11 and ATG28 interact with Pex14, which tags
peroxisomes for vacuolar engulfment – a process completed by the formation of the
micropexophagic membrane apparatus (MIPA) (Mukaiyama, Baba et al. 2004) (Figure
1.6). Peroxisomes are subsequently degraded in the vacuolar lumen by hydrolases.
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Figure 1.6. The two models of pexophagy: macro- and micropexophagy. Depicted
are morphological intermediates and the corresponding proteins relevant for each step.
(A) After initiation of micropexophagy, the peroxisomes (purple) become engulfed by
invagination of the vacuolar membrane (red). In addition, the micropexophagy apparatus
(MIPA; green) is required for complete sequestration of peroxisomes. Finally, the
peroxisomes are degraded in the vacuolar lumen by hydrolases. (B) Macropexophagy is
specific to mature peroxisomes, which are recognized by a sequestration membrane (SM;
green single membrane). Completion of sequestration produces the pexophagosome (PP,
green double membrane), which represents one peroxisome engulfed by two membranes.
The outer membrane of the pexophagosome fuses with the vacuolar membrane, resulting
in the release of the peroxisome (which is still surrounded by the inner membrane) into
the lumen of the vacuole, and its subsequent degradation.
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1.6 Regulation of peroxisome size and number
1.6.1 Proteins involved in peroxisome proliferation
The molecular machinery involved in peroxisome proliferation and division is
becoming well characterized. The first protein identified as a regulator of peroxisome
size and number was Pex11 in Saccharomyces cerevisiae (van Roermund, Tabak et al.
2000). Mutation analyses of Pex11 in S. cerevisiae indicated that disruption of Pex11
resulted in the formation of few giant peroxisomes per cell, whereas its overexpression
induced the formation of multiple small peroxisomes. A similar ability to promote
peroxisome proliferation was also reported for human (Abe and Fujiki 1998; Schrader,
Reuber et al. 1998; Li and Gould 2002), rodent (Passreiter, Anton et al. 1998), protozoan
(Maier, Lorenz et al. 2001), isoforms of Pex11.
There are three isoforms of Pex11, -α, β and γ, which, based on gene knockout
and overexpression analyses, differ in expression pattern and phenotypic consequences.
The α and γ-isoforms are believed to stimulate peroxisome divisions in response to
metabolic cues (Schrader, Reuber et al. 1998).

Recently, it was shown that Pex11β

participates in peroxisome division by inducing membrane elongation and shape changes
in preexisting peroxisomes (Figure 1.7). Elongated membranes on existing peroxisome
form small blebs and separate into new peroxisomes with the aid of dynamin-like
proteins (DLPs), Pex25 and Pex27 (Delille, Agricola et al. 2010), while separation of the
divided, yet clustered peroxisomes is subsequently controlled by Pex28 and Pex29
(Figure 1.7). The role of Pex11β and its pivotal role in regulating peroxisome number is
a key element investigated in this thesis.
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Figure 1.7. Division cycle of peroxisomes. Peroxisomal membrane proteins Pex11β,
Pex25 and Pex27, and dynamin-related protein 1 (DLP1) are involved in peroxisome
membrane elongation, constriction and fission. Pex28 and Pex29 mediate separation of
the newly divided, yet clustered peroxisomes.

Newly synthesized preperoxisomal

vesicles mature into functional peroxisomes following further matrix protein import.
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1.6.2 Metabolic control of peroxisome abundance
The metabolic regulation of peroxisome abundance is poorly understood. In
mammalian cells, defects in peroxisomal fatty acid β-oxidation result in reduced
peroxisome abundance (Chang, South et al. 1999). Cellular analyses of peroxisomes
from patients with specific deficiencies in acyl-CoA oxidase displays enlarged
peroxisomes that are heterogeneous in size (Poll-The, Roels et al. 1988). Additionally,
mammalian cell lines mutant for acyl-CoA display a 5-fold reduction in peroxisome
abundance compared with normal cells (Chang, South et al. 1999). Another enzyme,
thioesterase, which inhibits peroxisomal fatty acid oxidation, was found to reduce
peroxisome abundance when overexpressed (Chang, South et al. 1999). These and other
findings shed insight on the metabolic role of peroxisomes, and how metabolism relates
to peroxisome numbers.

1.6.3 Signals and events leading to peroxisome proliferation
Peroxisomes can rapidly adapt to cellular demands and increase in both size and
number. In mammalian cells it is well known that PPARα mediate the induction of
peroxisome proliferation (Yu, Cao et al. 2001). However in yeast, the transcription factor
alcohol dehydrogenase regulation 1 (Adr1) is involved in peroxisome division and
supports a mechanistic model for the divisionary process. Adr1 regulates the expression
of acyl-CoA oxidase and interacts with Pex16 found on the matrix face of the
peroxisomal membrane (Guo, Kit et al. 2003). These interactions are believed to trigger
the formation of a trans-bilayer composed of a distinct set of lipids that constitute a
specific platform on the surface of the peroxisome.

This platform is used for the
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assembly of the division machinery (Guo, Gregg et al. 2007), like Pex11β, which induces
the elongation process and increases peroxisome numbers.
Peroxisome numbers may fluctuate in response to changes in metabolic demand,
and the number of peroxisomes may have an important influence on ROS levels not only
within these organelles, but also within the cytoplasm (del Rio, Sandalio et al. 2006).
While elevated levels of ROS are considered deleterious to cellular constituents like
proteins, nucleic acids and lipids, low levels are involved in regulating cell signaling
cascades and protein modification (Covarrubias, Hernandez-Garcia et al. 2008).
Therefore, peroxisome numbers may also serve to regulate ROS such that proper cell
signaling can occur.

Understanding the relationship between peroxisome number and

ROS levels, and the ability for these factors to influence ROS signaling cascades is a key
element of this thesis.

1.7 ROS as signaling molecules
At low cellular concentrations, ROS behave as secondary messengers that may
partake in a variety of cellular responses via protein redox (reduction-oxidation)
modifications.

Typically, redox modifications occur at cysteine residues, however,

amino acids such as tryptophan, tyrosine and histidine may also undergo similar changes.
Cys thiols (SH) are subjected to different degrees of oxidation by various ROS resulting
in the generation of sulphenic acid (SOH), sulphinic acid (SO2H) or sulphonic acid
(SO3H). Additionally, SOH reacts with a second cysteine either in the same or a second
protein to yield a disulphide bond. The variety of macromolecules sensitive to redox
modifications ranges from phosphatases, kinases, a large number of transcription factors,
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and other proteins such as matrix metalloproteinases (MMPs), which are involved in
extracellular matrix remodeling (Paulsen and Carroll 2010). ROS, like other secondary
messengers, can in addition alter the activity of proteins, mediating various biological
responses including gene expression, cell proliferation, angiogenesis, programmed cell
death and senescence.
Alternatively, it is also known that increased levels of these short-lived reactive
molecules can exert harmful effects by causing oxidative damage to biological
macromolecules and disrupting the oxidation state of the cell. To neutralize and protect
cellular constituents, cells employ many enzymatic defense mechanisms. Antioxidants
partake in the detoxification of ROS, which prevent these deleterious byproducts from
causing potential injuries. Antioxidants reduce ROS species such as H2O2, and in the
process they become oxidized.

Oxidized elements are then either eliminated or

continually recycled through further reduction steps. Biological antioxidants include
organic compounds, such as GSH, vitamins A and E, and importantly, genetically
encoded enzymes. The latter group includes proteins such as catalase, SOD, and a
variety of peroxidases such as Gpx, and Prdx. Some antioxidants are localized to specific
subcellular compartments, while others are involved in the global scavenging ROS.

1.7.1

ROS metabolism in peroxisomes
Mitochondria are the primary source of ROS production due to their high metabolic

state. However, recent studies have demonstrated the ER and particularly, peroxisomes
are key regulators in balancing the redox state of a cell (Schrader and Fahimi 2004).
Peroxisomes contain a variety of antioxidants to counteract oxidative stress resulting
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from metabolism and other peroxisomal processes, which contributes to redox balance.
Imbalance in peroxisomal ROS may damage biomolecules, perturb cellular thiol levels,
and deregulate cellular signaling pathways. In recent years, peroxisomal ROS
metabolism and signaling have become the focus of a rapidly evolving and
multidisciplinary research field (Fransen, Nordgren et al. 2011).

1.7.2 Peroxisomal ROS metabolism and human disease
It is well accepted that alterations in the cellular oxidation state impose a
considerable risk for the onset of various diseases and aging. As the intracellular redox
state is inherently linked to metabolism, it is becoming increasingly apparent that
peroxisomes are involved in human pathologies related to oxidative stress.

In this

context, it is interesting to note that compromised catalase activity has already been
associated with ischemia-reperfusion injury, hypertension, skin pigmentation disorders,
retinal

disease,

degenerative

joint

disease,

heart

failure,

type

2-diabetes,

neurodegenerative disorders, and the initiation and progression of certain cancers
(Koepke, Wood et al. 2008).

1.7.3

ROS during animal development
Some developmental processes are almost completely anaerobic, whereas others

are ROS-dependent. The spatiotemporal distributions of ROS vary accordingly across
different stages of development in various organisms. In mammals, preimplantation and
early postimplantation embryogenesis occurs under almost anaerobic conditions, giving
insight to the sensitivity of these processes to oxidative stress conditions (Hernandez-
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Garcia, Wood et al. 2010). High ROS levels are detrimental for growth of embryos in
culture, and administering free radical scavengers improves in vitro embryo development
(Covarrubias, Hernandez-Garcia et al. 2008).

Oxygen toxicity in embryos is well

documented, however, direct evidence for the function of ROS in specific developmental
processes has only recently become a topic of interest. Developmental processes such as
spermatogenesis, oogenesis, fertilization, morphogenesis, angiogenesis and cell migration
have all received much attention in terms of their association with ROS (Covarrubias,
Hernandez-Garcia et al. 2008). For example, during morphogenesis in mouse embryos,
high ROS concentrations are associated with the cell death that occurs in the interdigital
regions of the developing limb. ROS levels in the limb appear to be regulated by Gpx4,
which the in mouse has a restricted expression pattern only in the limb region (Schnabel,
Salas-Vidal et al. 2006). The roles of ROS in development are becoming increasingly
well understood.

One function of ROS that has received much attention in

developmental models such as X. laevis, is its role in the redox-regulated mechanisms of
Wnt signaling.

1.7.4 Redox regulation of Wnt signaling
Wnt ligands are utilized in many normal developmental processes including
differentiation, pattern formation and proliferation (Clevers 2006). The canonical Wnt
signaling pathway ultimately results in the accumulation of β-catenin and its
translocation to the nucleus, where it activates the transcription factor Lef/Tcf (Figure
1.8A). In order for this to occur, Wnt ligands bind to the Frizzled (Fzd) receptor causing
inhibition of the destruction complex, resulting in the cytosolic accumulation of β-catenin
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– a process mediated by a protective protein called Dishevelled (Dvl). Recent studies on
Wnt signaling in X. laevis indicate a redox-sensitive switch for this pathway. It was
determined that nucleoredoxin (Nrx), a thioredoxin-related protein, plays a regulatory
role in canonical Wnt signaling by directly controlling Dvl activity (Funato, Michiue et al.
2008). Nrx binds to Dvl in its reduced form, which suppresses Wnt signaling. In X.
laevis embryos, increasing or decreasing Nrx protein level results in embryonic
abnormalities, which relate to inhibition or activation of Wnt signaling, respectively.
These studies also determined that H2O2 oxidizes Nrx, releasing it from Dvl, thus
promoting β-catenin accumulation in the absence of Wnt ligand. In addition to canonical
Wnt signaling, the noncanonical Wnt/PCP signaling pathway controls cytoskeletal
changes through the activation of Rho and c-Jun N-terminal kinase (JNK) signaling
cascade (Figure 1.8B).

Similarly to the canonical pathway, the Wnt/PCP signaling

involves Nrx and Dvl, via redox-sensitive activation, which are involved in regulating
Xenopus gastrulation movements (Funato, Michiue et al. 2008). From this data, it is
predicted that ROS levels are a determinant for the activation of the canonical and
noncanonical Wnt signaling pathways, and therefore ROS must be tightly regulated to
maintain the balance necessary for normal embryonic development.
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Figure 1.8. Schematic representation of Wnt/β-catenin and Wnt/PCP cell signaling
pathways. (A)Wnt/β-catenin signaling is initiated by association of Wnt with Frizzled at
the plasma membrane, leading to the inhibition of β-catenin degradation complex
(Axin/APC/GSK-3β), which permits the accumulation of β-catenin and its translocation
to the nucleus to activate target gene transcription by associated with Lef/Tcf
transcription factors. (B) Wnt/planar cell polarity (PCP) is initiated by association of
Wnt with Frizzled at the plasma membrane, resulting in the activation of Rho and Rac
GTPases. Activation of Rho involves the activation of the Rho-associated kinase, Rock,
whereas Rac activation stimulates c-Jun N-terminal kinases (JNK) activity,
phosphorylating c-Jun and consequently phosphorylates AP-1 transcription factors.
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1.8 Animal Model
The model system used in these studies was the African clawed frog Xenopus
laevis. Classified in 1802 by Francois Marie Daudin, embryos of this species have been
an important model organism for developmental biologists since the 1800’s. Although X.
laevis does not have the short generation time and genetic simplicity generally desired in
model organisms, it is an important organism in developmental biology. X. laevis takes 1
to 2 years to reach sexual maturity and, like most of its genus, it is tetraploid. However,
embryos are large and easily manipulated, which has given them an important status in
the study of developmental biology.
X. laevis has well characterized embryological pathways, cellular movements and
detailed fate maps (Appendix B). Controlled ovulation can be induced by injection of
commercially available human gonadotropin hormone the evening before morning
ovulation. One female can yield hundreds of embryos in a single in vitro fertilization,
which may be repeated with the same female every four months. Embryos are large and
durable, making them suitable for in vitro culturing at room temperature in a serum free
salt solution. They are also resilient to a variety of invasive experimental techniques such
as embryo manipulation and microinjection. Lastly, A6 cells, which are cloned epithelial
cells from the X. laevis kidney, have been used as an in vitro model. As such, X. laevis
has been pivotal in aiding our understanding of key early signaling events. For these
reasons I have chosen to use X. laevis as the model organism to study peroxisome
biogenesis and its relationship to ROS and cell signaling events.
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1.9 Research Questions
1.9.1

Summary
Peroxisome division is a multistep, highly coordinated serious of events. Proteins

termed peroxins, synthesized by peroxisome biogenesis factors (Pex), are responsible for
these events. Peroxisomes have many important roles, and their number and function is
crucial for normal cellular physiology. The consequences of perturbation or dysfunction
of peroxisomes is emphasized in a spectrum of lethal diseases termed peroxisome
biogenesis disorders. Recently, it has been established that the Pex11-family of peroxins
is involved in the regulation of peroxisome division through membrane elongation (Koch,
Pranjic et al. 2010). In this study I first examine the role of Pex11β and its relationship to
the regulation of peroxisome division. As the mechanisms of peroxisome division are
becoming well understood, very little is known regarding the relationship between
peroxisome numbers and the redox (reduction-oxidation) state of cells. Peroxisomes are
primarily involved in the β-oxidation of very-long chain fatty acids, producing high
levels of reactive oxygen species (ROS) that are eradicated by a dynamic antioxidant
defense system.

Therefore, I also examine how ROS levels change in response to

alterations in peroxisome number. As ROS are known as secondary molecules that
contribute to protein modification and activity, I examine how changes in ROS levels,
resulting from altering peroxisome numbers, contribute to the redox sensitive
mechanisms of Wnt signaling. Taken together, this study sheds light on the relationship
between peroxisome number, ROS levels and cell signaling, which could improve our
understanding the progression of fatal human peroxisome disorders.
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1.9.2

Objectives
The goal of this study is to examine the relationship between Pex11β and

peroxisome number, and then, to elucidate how changes in peroxisome numbers affect
ROS levels, and in turn how the imbalance in ROS may alter Wnt signaling. This will be
achieved by examining and completing the following objectives:
1)

Elucidate the relationship of Pex11β to peroxisome number in vitro and in vivo.

2)

Establish how peroxisome number regulates ROS levels in vitro.

3)

Determine that changes in ROS result in abnormal Wnt signaling in vitro.

1.9.3
1)

Hypotheses
Overexpression and inhibition of Pex11β will increase or decrease the number
of peroxisomes in X. laevis A6 cells, respectively.

During X. laevis

embryogenesis, overexpression of Pex11β will induce early-onset of
peroxisome biogenesis, while inhibition of Pex11β will result in late-onset of
peroxisome biogenesis and the appearance of fully functional peroxisomes.
2)

Peroxisome number has a direct effect on the levels of ROS. Modifications to
peroxisome number via changes in Pex11β expression will directly affect the
levels of H2O2 and the levels of global and mitochondrial ROS, in vitro.

3)

Alterations to the levels of ROS will result in redox modifications to Wnt
signaling, in vitro.
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CHAPTER 2
PEX11-ΒETA INDUCES PEROXISOMAL GENE EXPRESSION AND ALTERS PEROXISOME
NUMBER DURING EARLY XENOPUS LAEVIS DEVELOPMENT.
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2.1 Introduction
2.1.1 Overview of peroxisomes
Peroxisomes are single-membrane bound organelles found ubiquitously in
eukaryotic cells. They house more than 50 matrix enzymes that participate in a diverse
array of metabolic processes including the β-oxidation of very long chain fatty acids
(VLCFA) and α-oxidation of long branched-chain fatty acids (Platta and Erdmann 2007).
Peroxisomes also contain oxidases that produce the corrosive byproduct hydrogen
peroxide (H2O2) (Singh 1997). H2O2 and other dangerous reactive oxygen species (ROS)
are then converted to innocuous products such as water and molecular oxygen by catalase
and other enzymes within the peroxisome and in other cellular compartments (Anand,
Kwak et al. 2009). Because of their complex roles in both cellular metabolism and ROS
elimination, peroxisome function is strongly related to cellular development and eventual
cellular senescence when their function begins to fail.
While cellular aging and senescence are well characterized by peroxisomal
dysfunction (Legakis, Koepke et al. 2002), little is known about the origin of these
organelles, particularly during embryonic development.

Important players in the

regulation of overall peroxisome numbers are the peroxisome proliferator-activated
receptors (PPARs), which were first identified in the early 90s in mice (Issemann and
Green 1990). Three types of PPARs have been identified (alpha, gamma, and delta) that
function as transcription factors and play critical physiological roles as lipid sensors and
regulators of lipid metabolism, as well in the regulation peroxisome numbers (Desvergne,
Michalik et al. 2006).
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2.1.2 Peroxisome biogenesis
Total peroxisome numbers and peroxisome biogenesis, involves the production of
proteins termed peroxins; nuclear encoded by Pex genes, synthesized on free
polyribosomes in the cytosol and post-translationally transported into the peroxisomal
matrix and membrane (Duhita, Le et al. 2010). Peroxins can facilitate peroxisomal
membrane function, biogenesis and division, and the transport of specific cytosolic
proteins into the peroxisomal matrix via one of two peroxisomal targeting signals (PTS)
(Dodt, Braverman et al. 1995). The PTS2 signal sequence is a complex amino terminal
signal composed of N/K-L-X5-Q-H/L, while the PTS1 consists of the C-terminal amino
acid sequence SKL and a conserved variant form, KANL (Wolf, Schliebs et al. 2010).
Studies have shown proteins with the SKL signal have a higher affinity for peroxisomes
than proteins with the relatively weaker KANL PTS1-signal (Koepke, Nakrieko et al.
2007).

In addition to various functions within peroxisomes, these cytoplasm-to-

peroxisome protein import pathways have been proposed as a necessary mechanism to
increase peroxisome numbers from existing peroxisomes (Ma and Subramani 2009).
While peroxisome number may be augmented though signal transduction (Li and Gould
2002), the total number of peroxisomes in a cell is regulated by; (i) peroxisome de novo
biogenesis, (ii) peroxisome proliferation by division and (iii) peroxisome degradation by
pexophagy, an autophagy-related process (Platta and Erdmann 2007).
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2.1.3 Pex11-family of peroxins
Multiple studies on Pex11 proteins have contributed to understanding their role in
peroxisome division, although the specific molecular mechanism that regulates their
function are poorly understood (Li and Gould 2002).

Expression levels of Pex11

peroxins are directly correlated with peroxisome numbers (Kaur and Hu 2009). For
example, a Pex11p knock-down in yeast significantly reduced the number of cellular
peroxisomes, whereas, Pex11p overexpression increase their numbers (van Roermund,
Tabak et al. 2000). A similar ability to promote peroxisome proliferation was also
reported in humans (Li and Gould 2002), rodents and protozoan models (Schrader and
Fahimi 2006).

All of these studies support a direct role for the Pex11-family in

peroxisome division in vitro, though little is known about their role during
embryogenesis.

2.1.4 Metabolism in vertebrate development
It is unknown whether peroxisomes exist in fertilized eggs, or in early stage
vertebrate embryos. While early frog development requires glycogen and lipid reserves
to be oxidized, and protein and yolk reserves to be metabolized, surprisingly little is
known about the regulation of yolk, vitellogenin and lipid metabolism in oviparous
animals such as frogs. Early histological staining studies revealed that yolk and lipid
utilization follow gastrulation, but preceded cell differentiation, suggesting the alterative
forms of yolk metabolism prior mid-blastula transition (MBT). Selman and Pawsey
revealed that frog yolk and lipid utilization took place ventral to the archenteron just prior
to stage 20, and within the developing myotomes by stage 23 (Selman and Pawsey 1965).
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Other histochemical studies have also shown that yolk and lipid metabolism occurs
within the somites as they begin to differentiate between stages 17-24 (Kielbowna 1975).
Yolk is then metabolized in most differentiating tissues in the embryo after stage 30
(Kielbowna 1975). This tissue specific utilization of yolk has been more recently
confirmed using a variety of approaches including the examination of pH changes, and
the involvement of proteases such as cathepsin D, and inhibitors such as
EP45/pNiXa/Seryp, a family of serine protease inhibitors (Fagotto 1995). This tissue
specific regulation of yolk metabolism during embryogenesis suggests complex
underlying developmental controls of these processes.

2.1.5 Hypotheses of overexpressing Pex11β
While peroxisomes are needed for metabolism and ROS regulation, their origins
and biogenesis within the embryo are poorly understood. Here I examine the level of
expression of peroxisomal genes Pex1, Pex3, Pex5, Pex11β, catalase and PMP70, as well
as PPARα, δ, and γ in a X. laevis cell line, and during embryonic development. I test the
hypothesis that Pex11β has the ability to induce peroxisomal gene expression in vitro,
and induce early increase in peroxisome number in vivo. My results demonstrate that
overexpression of Pex11β can increase the number of peroxisomes in A6 cells in vitro,
and induce an early-onset to peroxisome-like structures during Xenopus embryogenesis
in vivo.

I propose that Pex11β plays a direct role in peroxisome divisions, and

additionally, regulating the timing of peroxisome biogenesis during X. laevis embryonic
development.
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2.2 Materials and Methods
2.2.1 Animal care
Adult X. laevis were reared in accordance with Canadian Council on Animal Care
regulations.

Fertilizations were performed according to Wu and Gerhart (Wu and

Gerhart 1991), and embryos were staged according to Nieuwkoop and Faber
(Nieuwkoop). Embryos to be sectioned were fixed in 4% formaldehyde at desired stages
and paraffin-embedded.

2.2.2 Cloning, RNA synthesis, and microinjection
I cloned Xenopus full length Pex11β [GenBank:MGC69071] from total adult
liver cDNA using specific primers and SuperScriptTM Reverse Transcriptase (Invitrogen)
with Platinum® Taq DNA Polymerase High Fidelity (Invitrogen) using conditions
supplied by the manufacturer. A 5’ HA tag was added to Pex11β using specific primers;
HA-Pex11β 5’AGA TCT TCA AGC GTA ATC TGG TAC GTC GTA TGG GTA GGG
CTT CAG CTT CAG CCA 3’ and 5’ CGA ACC CAC GAG TCC ATA CTA GT 3’. I
also engineered GFP tagged with the PTS1 SKL, using forward 5’ AGA TCT ATG GTG
AGC AAG GGC GAG 3’ and 5’ ACT AGT CTA TAA TTT GGA CTT GTA CAG CTC
GTC CA 3’.

PCR products were cloned into the pCR®II-TOPO vector as per

manufacturer’s instructions (Invitrogen). Recombinant sequences were confirmed at the
Robarts Research Institute DNA Sequencing Facility at the University of Western
Ontario. Desired clones were additionally cloned into pcDNA™TOPO 3.3® TA Cloning
`Kit (Invitrogen) for cell culture experiments, and T7TS plasmid and sequenced in vitro
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RNA production.

Capped polyadenylated RNA was synthesized using mMachine

mMessage® T7 (Ambion) and visualized on a 1.0% agarose formaldehyde gel to ensure
quality and transcription validity. Embryos at the one-cell stage in 4% ficoll in 1X Marks
Modified Ringer (MMR) solution were microinjected with approximately 1 ng of desired
RNA. Following 4 hours, embryos were transferred to 0.1X MMR for rearing.

2.2.3 Cell lines, transfections and immunocytochemistry
A6 cells derived from X. laevis epithelial cells (generous gift from Dr. John
Heikkila, University of Waterloo, ON) were grown in Leibowitz-15 media (with 10%
FBS and 1% penicillin and streptomycin) at room temperature. All transfections were
completed using Lipofectamine Plus LTX Transfection Reagents (Invitrogen) according
to manufactures protocol.

For immunofluorescence, cells were fixed in 3.7%

formaldehyde in Dulbecco's modified PBS (DPBS) (Invitrogen), pH 7.4, for 10 min, and
permeabilized in 1% Triton X-100 in DPBS for 10 min. Cells were incubated with either
PMP70 (Abcam, ab4965) or catalase (Cedarlane), and/or haemagglutinin (Invitrogen)
polyclonal antibodies for 3 hours, washed three times in PBST for 5 minutes each,
incubated with fluorescently labeled secondary antibodies for 1 hour, washed again for 5
minutes in DPBS, and mounted on slides using ProGold mounting media (Invitrogen).
Samples were visualized with a Zeiss AxioStop 2 Mot. Images were captured with a
Retiga 1600 camera (Qimaging) and fluorescence quantifications were completed using
Northern Eclipse image capture and analysis software (Empix).
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2.2.4 RNA isolations and reverse transcriptase PCR (RT-PCR)
RNA was isolated from cell lysates of all samples two days following transfections.
Total RNA was isolated with an RNeasy kit (QIAGEN) from embryos at developmental
stages 10, 20, 30, and from A6 cells, was evaluated on a 1.0% agarose formaldehyde gel.
Synthesis of cDNA was completed with SuperScript II Reverse Transcriptase
(Invitrogen) following manufactures protocol. To analyze RNA expression levels during
development, RT-PCR primers were designed against known Xenopus peroxisomal and
PPAR genes with the following accession numbers: Pex3 [EMBL:AAH73069.1], Pex5
[NP_001011381],
[BC054964]

Pex11β

Pex1

[GenBank:MGC69071],

[NM_001091972.1],

PPARα

PMP70

[EF07060],

catalase

[NM_001095362],

PPARδ

[NM_001087841], and PPARγ [NM_001087843] Mid-log phase RT-PCR products were
visualized on a 1% agarose gel and unsaturated band intensities were quantified against
control elongation factor-1α [NCBI: NM_001087442] with Quantity One software
(Version 4.4.0 Bio-Rad). All quantified PCR reactions were completed in triplicate. The
amplicons of peroxisomal genes listed above were cloned with the TOPO-TA Cloning®
(Invitrogen) system as described by the manufacturer's protocol and sequenced to ensure
gene identities.

2.2.5 Western blot analysis
PMP70 (Abcam, ab4965), catalase (Cedarlane), hemagglutinin and β-actin
(Invitrogen) polyclonal antibodies were used to detect protein from both X. laevis A6 cell
lysates before and after treatments. Bradford protein quantifications were used to ensure
that equivalent amounts of protein (10 µg) were loaded for each sample (Bradford 1976).
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Primary antibodies were used in a 1 in 1000 dilution and secondary 1 in 10,000 dilution,
and blots were developed using an enhanced chemiluminescence kit (Amersham). Band
intensities were quantified using Quantity One software (Version 4.4.0 Bio-Rad).

2.2.6 Immunohistochemistry
Paraffin-embedded embryo sections were washed in Xylene and re-hydrated by
washing in 100, 90, 80 and 70% ethanol each for 10 minutes twice, followed by 10 min
in 0.1% Tween-20 in PBS twice.

Histology sections to be immunostained were

incubated with a 24-hour primary followed by a two-hour secondary (FITC or Texas Red
conjugated) antibody incubation in a 1 in 100 antibody dilution.

Embryos were

counterstained with DAPI (Invitrogen) according to the manufacturer's protocol. Images
were captured and fluorescence quantified with a Zeiss LSM Dou (Live 5 Vario II and
510 Meta) Confocal system using Northern Eclipse image capture and analysis software
(Empix).

2.2.7 Statistical analyses
Tests of significance are described within the legend of the figure as required.
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2.3 Results
2.3.1 Pex11β altered the RNA levels of peroxisome related genes in X. laevis A6 cells.
We first investigated if Pex11β could alter the RNA levels of the peroxisome
related genes Pex1, Pex3, Pex5, Pex11β, catalase, PMP70, PPARα, -δ, and -γ in X. laevis
A6 kidney epithelial cells, which has not been previously demonstrated in Xenopus
before. A6 cells were transfected with plasmids designed to express Xenopus HAPex11β, or control full-length GFP. Semi-quantitative RT-PCR analyses revealed a
significant increase in Pex11β, PMP70, catalase, Pex5 and PPARα, but a significant
decrease in PPARγ mRNA levels, following HA-Pex11β overexpression in A6 cells
(Figure 2.1). No significant changes were found in levels of Pex3, Pex1, nor in PPAR δ
mRNA (Figure 2.1).

2.3.2 Pex11β increased hallmark peroxisomal protein levels in X. laevis A6 cells.
Since overexpression of HA-Pex11β increased the mRNA levels of catalase and
PMP70, we next wanted to determine if there were actual increases in the protein levels
of these hallmark peroxisomal proteins.

A6 cells were transfected as previously

described and protein samples were isolated for Western blots. Using HA specific
antibodies, Western blot analysis confirmed bands of expected sizes for HA-Pex11β (63
kDa) in transfected samples (Figure 2.2), confirming the integrity of the HA-tagged
construct. Western blot analyses with catalase and PMP70 specific antibodies also
revealed bands of expected sizes for both PMP70 (70 kDa) and catalase (55 kDa) (Figure
2.2). A significant increase in catalase and in PMP70 were found following HA-Pex11β
overexpression versus control untransfected samples (Figure 2.2A, left three GFP lanes
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versus right three HA-Pex11β lanes, and quantified in Figure 2.2B). The use of anti-βactin demonstrated the relative protein levels in each lane.
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Figure 2.1. Overexpressing HA-Pex11β altered peroxisome related gene expression
in Xenopus A6 cells. RT-PCR analysis of peroxisomal genes was performed before and
after transfection of A6 cells with HA-Pex11β. Two days following transfection 250 ng
of reverse-transcribed A6 cell RNAs from control and treatment samples (n=3) were
subject to PCR amplification using specific primers for the peroxisome related genes;
Pex11β, PMP70, catalase, Pex5, Pex3, Pex1, PPARα, -δ, and -γ. The respective mRNA
levels represent measures of mid-log phase RT-PCR product band intensities, relative to
levels of EF1α. Genes whose levels were altered significantly as assessed by a paired
sample t-test are denoted with an asterisk. Pex11β, PMP70, catalase, Pex5 and PPARα
displayed elevated levels of expression following treatment, while PPARγ displayed
reduced expression. P<0.05, n=3. Values presented are the means ± SE.
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Figure 2.2. Overexpression of HA-Pex11β in A6 cells increased catalase and PMP70
protein levels. Western blotting revealed elevated proteins levels of catalase and PMP70
following the transfections of HA-Pex11β, but not GFP, in three samples of A6 cells (A).
An HA antibody confirmed the translation and presence of HA-Pex11β in transfected
cells (right 3 lanes) versus GFP transfected control cells (left 3 lanes). Catalase and
PMP70 antibodies also displayed altered band intensities of each respective protein in
HA-Pex11β transfected cells (right 3 lanes) versus GFP transfected cells (left 3 lanes).
Protein loading in each lane was confirmed via a β-actin antibody. The Western blot
signals were digitized and data were quantified and analyzed to statistically compare
protein levels (B). There was a significant increase in the levels of catalase and PMP70
following overexpression of Pex11β, while there was no difference in the levels of βactin. Statistical relevance of discrepancies between groups (asterisks) was assessed by a
paired sample t-test. P<0.05, n=3. Values presented are the means ± SE.
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2.3.3 Overexpression of Pex11β increased peroxisome numbers in X. laevis A6 cells.
Although recent studies in several eukaryotic cell lines has revealed that Pex11proteins can independently increase peroxisome-like structures (Selman and Pawsey
1965), I tested the hypothesis that Pex11β could induce an early onset to peroxisome
biogenesis during Xenopus embryogenesis. I first tested whether overexpression of
Pex11β could increase peroxisome-like structures and peroxisome number in X. laevis
A6 cells.

Two days following transfection of HA-Pex11β, cells were fixed for

immunocytochemistry and probed with PMP70 and catalase antibodies. This allowed us
to examine the distribution of PMP70 and catalase protein, and also to quantify their
relative protein levels using a fluorescent secondary antibody. Our results indicated that
overexpression of HA-Pex11β significantly increased the amounts of both catalase levels
(Figure 2.3A versus B) and PMP70 levels (Figure 2.3D versus E) versus control, as
determined by quantifying the relative levels of indirect fluorescent; catalase indirect
fluorescence levels increased >3 fold (Figure 2.3C), while PMP70 indirect fluorescence
levels increased >2.5 fold (Figure 2.3F).
As the increased levels of PMP70 and catalase fluorescent signals may not
specifically be related to peroxisome function, I next tested if overexpression of HAPex11β could also increase the number of peroxisomes using the peroxisomal marker
GFP-SKL as a detection assay. This PTS1 tagged GFP will localize to punctate-like
structures in the cytosol when imported into peroxisomes. A6 cells were co-transfected
with HA-Pex11β and GFP-SKL, or GFP-SKL alone. Two days following transfection,
peroxisome-like structures were assessed by direct immunofluorescence. Our results
showed a significant increase in the number GFP-containing bodies (>2-fold, Figure 2.3I)
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in cells that expressed HA-Pex11β versus cells transfected with GFP-SKL alone
(compare Figure 2.3G and H).
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Figure 2.3. Overexpression of HA-Pex11β in A6 cells increased peroxisome
numbers. A, D, G are untransfected cells, while B, E, H have been transfected with HAPex11β. G and H are additionally transfected with GFP-SKL. Using identical imaging
and photography parameters, indirect immunofluorescence using a catalase antibody
revealed lower levels of immunofluorescence in untransfected cells (A) versus
transfected (B) cells. Similarly, indirect immunofluorescence using a PMP70 antibody
revealed lower levels of signal in untransfected cells (D) versus transfected (E). Direct
fluorescence for GFP revealed a diffuse signal from GFP in HA-Pex11β untransfected
cells, (G) versus the presence of punctate structures in HA-Pex11β transfected cells (H).
All images were captured using identical fluorescent settings. The relative fluorescence
intensity in 10 regions of twenty randomly imaged cells was quantified using Northern
Eclipse software. Graphs on the right represent the average fluorescence intensity of
untransfected versus HA-Pex11β transfected cells. Values presented are the means ± SE.
Significance at P<0.05 was determined using Student’s t-test, n=25.
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2.3.4 Pex11β increased peroxisome related gene expression during X. laevis
embryogenesis.
I next examined the effects of increased Pex11β in vivo, by investigating changes
in expression of specific peroxisomal genes, following the microinjection of HA-Pex11β
RNA into early Xenopus embryos. To establish a base line, the temporal expression of
five peroxisomal genes were first analyzed during the developmental stages of
gastrulation (stage 10), neural tube closure (stages 20) and organogenesis (stage 30). In
general, with the exception of Pex5, all peroxisomal genes examined in control embryos
increased in expression as development progressed, with their lowest expression levels at
stage 10, and highest at stage 30 (Figure 2.4, significance between stages denoted by
double asterisks).

Pex5 expression in control embryos does not vary significantly

between stages 10 and 30. The increase in PMP70 RNA level between stages 10 and 20,
differs from a previously described decreasing trend between stages 12 and 20 (Marteil,
D'Inca et al. 2010). This discrepancy cannot be explained, but may to due to differences
in staging. Following microinjection of HA-Pex11β RNA there were significantly
increased RNA levels of catalase and PMP70 at stages 10, 20 and 30 (Figure 2.4, single
asterisk) versus control RNA levels of expression for each gene. Microinjecting HAPex11β also resulted in significant increases of Pex3 at stages 10 and 30, as well as Pex5
at stages 20 and 30. There were no significant changes in Pex3 at stage 20, nor Pex5 at
stage 10. Changes in Pex11β levels following microinjection of HA-Pex11β reflect the
presence of the HA-Pex11β construct.
Further, as ectopic Pex11β significantly decreased PPARγ RNA levels in A6
cells, we investigated whether ectopic Pex11β would similarly alter PPAR levels within
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embryos. The injection of Pex11β into embryos significantly increased levels of PPARα,
significantly decreased levels of PPARγ, but did not change levels of PPARδ RNA
(Figure 2.5), a pattern similar to that seen in the A6 cells.
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Figure 2.4. Embryonic overexpression of HA-Pex11β elevated Pex3, catalase and
PMP70 levels. The respective mRNA levels represent measures of mid-log phase RTPCR product band intensities, relative to levels of EF1α. RT-PCR analysis during normal
embryogenesis revealed that the levels of all genes examined, with the exception of Pex5,
increased as development progressed. First, a repeated measures ANOVA was carried
out entering all RNA levels at all 3 stages. When significant, a paired sample t-test was
carried out between levels at a given stage in control embryos. This would reveal
significant changes in RNA levels of the genes examined during normal development.
Significant changes in RNA levels a gene between stages is represented by the double
asterisk ** (P<0.05). Expression increases with development and there are differences in
the levels of Pex3 and PMP70 between all stages, 10vs20, 20vs30 and 10 versus 30. For
catalase there are differences between stages 10vs20 and 10vs30 but NOT between 20
versus 30. There are no significant differences in RNA levels between the tested
developmental stages for Pex11β or Pex5. As the means were correlated, a MANOVA
was carried out on the means of the treatment and control groups at each stage to see
whether there were differences in the RNA level of each gene at a given stage, following
the Pex11β treatment. As the MANOVA showed a significant effect of condition, a
Wilks lambda analysis was used, and the univariate ANOVAs showed that Pex11β
treatment resulted in significantly higher levels of gene expression, as represented by the
single asterisk * (P<0.05).

Pex11β, catalase and PMP70 all displayed significant

increases in RNA levels all stage 10, stage 20 and stage 30 following treatment. Pex3
displayed elevated expression at only stage 10 and 30, while Pex5 displayed differences
only at stages 20 and 30. n=3. Values presented are the means ± SE.
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Figure 2.5. Overexpression of HA-Pex11β did altered PPARα and γ, but not δ, gene
expression during early X. laevis embryogenesis. The respective mRNA levels
represent measures of mid-log phase RT-PCR product band intensities, relative to levels
of EF1α. Using a similar approach and analysis as used in Fig. 4, RT-PCR analysis of
RNA isolated from control stage 10 embryos and HA-Pex11β injected embryos revealed
significant changes in the expression of PPARα, and PPARγ, but not PPARδ. PPARα
levels were elevated by treatment, while PPARγ levels were redueced. P<0.05, n=3.
Values presented are the means ± SE.
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2.3.5 Catalase and PMP70 antibodies reveal early punctate organelle structures during
X. laevis embryogenesis following Pex11β injections.
To determine if Pex11β could induce an early onset to peroxisome-like structures
during Xenopus development, I used immunohistochemistry to visualize changes in the
embryonic distribution of PMP70 and catalase, in response to microinjecting HA-Pex11β
RNA. Fertilized embryos were microinjected with HA-Pex11β RNA, fixed at stages 10
and 20, and sectioned for immunohistochemistry. PMP70 and catalase signals were
undetected in stage 10 under control conditions (Figure 2.6A and 2.7A) using specific
antibodies. Punctate structures were visualized within the somites at stage 20 in control
sections, using PMP70 (Figure 2.6B), and catalase (Figure 2.7B) specific antibodies.
Following microinjection of HA-Pex11β, I were able to detected punctate PMP70 (Fig.
6C) and catalase (Fig. 2.7C) signals at stage 10 in pre-somitic mesoderm, and increased
levels of immunofluorescence for both proteins in stage 20 somites compared to control
uninjected embryos (compare Figure 2.6B vs 2.6D, and 2.7B vs 2.7D).
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Figure 2.6. Microinjecting HA-Pex11β RNA increased PMP70 immunofluorescence
levels during X. laevis embryogenesis. Both control (A and B) and HA-Pex11β injected
(C and D) embryos at developmental stages 10 (A and C) and 20 (B and D), were fixed
then sectioned for immunohistochemical analysis in somites for PMP70. At stage 10
PMP70 protein is undetected in somitic mesoderm under control conditions (A), whereas
following microinjection of HA-Pex11β PMP70 protein is detectable in punctate
structures (C). At stage 20, PMP70 protein was detected in both control and following
microinjecting HA-Pex11β (B and D). An HA antibody was also used to confirm the
ectopic presence of HA-Pex11β. DAPI (blue), PMP70 (green), HA-Pex11β (red),
colocalization of HA-Pex11β and catalase (yellow).
magnification.

Images were taken at 60x
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Figure 2.7. Microinjecting HA-Pex11β RNA increased catalase immunofluorescence
levels during X. laevis embryogenesis. Both control (A and B) and HA-Pex11β injected
(C and D) embryos at developmental stages 10 (A and C) and 20 (B and D), were fixed
then sectioned for immunohistochemical analysis in somites for catalase. At stage 10
catalase protein is undetected in somitic mesoderm under control conditions (A), whereas
following microinjection of HA-Pex11β catalase protein is detectable in punctate
structures (C). At stage 20, PMP70 protein was detected in both control and following
microinjecting HA-Pex11β (B and D). An HA antibody was also used to confirm the
ectopic presence of HA-Pex11β. DAPI (blue), PMP70 (green), HA-Pex11β (red),
colocalization of HA-Pex11β and PMP70 (yellow).
magnification.

Images were taken at 60x
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2.3.6 Overexpression of Pex11β triggered an early-onset to peroxisome accumulation
during Xenopus embryogenesis.
In order to determine when peroxisomes are first present during embryonic
development, focusing on the dorsal mesoderm, I microinjected GFP-SKL into earlyfertilized embryos.

Histological sections taken of developmental stage 10 embryos

revealed that peroxisomes were not visible, as GFP-SKL revealed a diffuse staining
pattern that lacked punctate structures (Figure 2.8A), similar to that seen in control GFP
injections embryos (data not shown).

However, GFP-containing punctate bodies,

indicative of peroxisomes, are readily visible in control embryos at stage 20 in the
somites (Figure 2.8B).
Next, I wanted to determine if overexpression of Pex11β could induce an
accumulation of peroxisomes, similar to how overexpression in A6 cells increased
peroxisome numbers.

Histological sections showed that ectopic expression of HA-

Pex11β in embryos resulted in the presence of punctate GFP-containing bodies at stage
10 (Figure 2.8C), versus the diffuse pattern of GFP-SKL seen at this stage in the dorsal
structures of uninjected embryos (Figure 2.8A). Further, there was also a relative increase
in the number of punctate structures at stage 20 following HA-Pex11β and GFP-SKL
(Figure 2.8D), compared to the microinjection of GFP-SKL alone (Figure 2.8B).
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Figure 2.8. Microinjecting HA-Pex11β RNA increased the number of peroxisomelike GFP-SKL structures during X. laevis embryogenesis. Both control (A and B) and
HA-Pex11β injected (C and D) embryos at developmental stages 10 (A and C) and 20 (B
and D), were fixed then sectioned for immunohistochemical analysis in somites for GFPSKL. At stage 10, GFP fluorescence is present as a faint diffuse stain under control
conditions (A), whereas following microinjection of HA-Pex11β punctate GFP structures
could be seen at this early stage (C). At stage 20, punctate GFP structures were detected
in both control and following microinjecting HA-Pex11β, where numbers were increased
in the injected samples. An HA antibody was also used to confirm the ectopic presence
of HA-Pex11β. DAPI (blue), GFP-SKL (green), HA-Pex11β (red), colocalization of HAPex11β and GFP-SKL (yellow). Images were taken at 60x magnification.
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2.4 Discussion
2.4.1 Role of Pex11β in peroxisome biogenesis in vitro
Pex11 proteins were first identified in yeast as peroxisomal membrane proteins that
could increase peroxisome number when overexpressed and significantly reduce
peroxisome number when interrupted (Karnati and Baumgart-Vogt 2009). Early studies
suggested that Pex11 proteins acted primarily on medium-chain fatty acid oxidation,
affecting peroxisome divisions indirectly (van Roermund, Tabak et al. 2000). Schrader
and colleagues were the first to show in human fibroblasts that overexpression of human
Pex11β was sufficient to induce peroxisome proliferation (Schrader, Reuber et al. 1998).
Recently, it has been shown that Pex11β participates in peroxisome divisions through
membrane elongation and shape changes of existing peroxisomes. Elongated membranes
fill with imported matrix proteins, form into small blebs and separate into new
peroxisomes with the aid of a dynamin-like protein (Delille, Agricola et al. 2010). While
yeast studies have shown that peroxisomes only arise through division (Motley, Ward et
al. 2008), and mammalian cell studies have suggested that they arise from both de novo
and division mechanisms (Kim, Mullen et al. 2006), little is known about peroxisome
biogenesis during embryonic development.

The question of peroxisome inheritance

remains largely unresolved, particularly as I have shown that peroxisomes are absent in
early frog embryos, and arise only later due to embryonic and or metabolic cues (Cooper,
Walsh et al. 2007).
I put to test whether overexpression of Pex11β could induce an early-onset to
peroxisome biogenesis or accumulation during early Xenopus embryogenesis. This is
particularly intriguing, as stage 10 embryos have no detectable peroxisomes. Thus, as
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Pex11β participates in peroxisome division, and no detectable peroxisomes are present in
early embryos, Xenopus represents a novel model where the role of Pex11β in
peroxisome number can be examined. The utility of microinjection and relative ease of
expression and localization assays enables specific questions related to Pex11β to be
addressed. First, I sought to show that Pex11β is sufficient to regulate peroxisome
related protein and RNA levels, and increase the number of peroxisomes in X. laevis A6
cells.

My RT-PCR analysis indicated significant increases in RNA levels for both

catalase and PMP70, amongst other genes, following overexpression of Pex11β. Using
Western blot analysis I confirmed that HA-Pex11β increased catalase and PMP70
proteins levels, and immunohistochemistry confirmed that HA-Pex11β increased the
number of both catalase and PMP70 positive punctate structures in A6 cells.
Additionally, as GFP-SKL can be transported into peroxisomes, co-transfection of HAPex11β and GFP-SKL revealed an increase in the number of peroxisome-like structures.
These results strongly support the idea that Pex11β can independently promote increases
to the number of peroxisomes in Xenopus A6 cells.

2.4.2 Role of Pex11β in peroxisome biogenesis in vivo
The primary focus of this study was to elucidate the role of Pex11β in vivo. Very
little is known about what cellular mechanisms regulate the de novo biogenesis of
peroxisome during Xenopus development. Using a different GFP-KANL reporter, I had
previously reported their detection at stage 30 in the ectoderm (Cooper, Walsh et al.
2007).

Histochemical studies in frog have suggested that yolk protein and lipid

metabolism occurs at different stages in different tissues (Mes-Hartree and Armstrong
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1980). Interestingly, early yolk metabolism is seen in the newly formed muscles – the
somites, but not in the large yolk-filled endodermal cells that are present on the ventral
side of the embryo (Mes-Hartree and Armstrong 1980).

Here, using HA-Pex11β and

other specific assays, I demonstrate that peroxisomes are detectable in somites at stage
20, but not at stage 10.
In agreement with the presence of peroxisome by stage 20, the RNA levels of most
peroxisomal genes examined changed temporally during early development. Pex11β
Pex3, Catalase, and PMP70 showed increasing trends in expression as development
proceeded, peaking stage 30, with cytosolic-bound peroxisomal receptor Pex5 not
varying during these stages. This suggested that transcripts are present and increasing
towards the eventual onset of peroxisome biogenesis and/or their subsequent
proliferation. These changes in Pex3 and Pex11β RNA levels relate well with previous
studies that have demonstrated their roles in division (Pinto, Grou et al. 2009). If
Pex11β, did play a key regulatory role, I next determined how microinjecting HAPex11β mRNA would affect the relative levels of key peroxisomal genes. Changes of
Pex11β RNA levels simply reflect and confirm the presence on the transfected construct.
The Pex11β resulted in the significant increases in RNA levels for catalase and PMP70 at
all stages tested (10, 20 and 30). There were also increases in the levels of Pex3 and Pex5
at two of the three stages examined, however, these changes were not as dramatic. From
this data, I conclude that Pex11β can play a role in the early induction of these
peroxisomal genes. Interestingly, as was examined with Pex11β in A6 cells, PPARα
RNA levels increased, PPARγ decreased, and PPARδ was unchanged by ectopic Pex11β
in embryos. Given that PPARα has roles in the β-oxidation of fatty acids, PPARγ a role
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in lipid catabolism and adipocyte differentiation, and that while expressed ubiquitously,
PPARδ functions remain unclear, the significance of our findings are not known.
Furthermore, the relationship between PPARs, other metabolic regulators, yolk utilization
and peroxisome numbers certainly bears further investigation.
I focused on the distribution of catalase and PMP70 protein within the somites and
found that catalase and PMP70 proteins are first localized as punctate structures
suggestive of peroxisomes at stage 20, with no detectable signal at stage 10.

To

corroborate this immunological finding I microinjected GFP-SKL RNA, whose product
could be transported into peroxisomes. Our stage 10 histology sections revealed diffuse
signals from GFP, indicating that peroxisomes are not yet present, as the SKL-tagged
GFP was not localized. However, we were able to show that GFP-SKL localized to
punctate-like structures in the somites at stage 20, indicating that peroxisomes are present
at this stage.

2.4.3 Pex11β induces an early-onset to the accumulation of peroxisomes during
embryogenesis
With these results in mind, I next tested whether microinjecting HA-Pex11β RNA
could induce an early accumulation to the number of peroxisomes. While peroxisomes
are present at stage 20, perhaps all needed precursors are present earlier in the embryo
and waiting a developmental or metabolic cue to form functional peroxisomes.
Following the microinjection of HA-Pex11β, I were able to visualize peroxisome-like
structures using GFP-SKL at stage 10.

This suggested that needed peroxisomal

precursors, including matrix proteins and other division proteins, such as dynamin-like
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proteins are present. Interestingly, together with the data that showed that HA-Pex11β
injections increased the transcription of peroxisomal genes, this suggests that Pex11β is a
key regulator of peroxisome onset and proliferation during Xenopus development. For
the very first time, I are able to show that Pex11β can independently induce an early
onset to peroxisome accumulation in vivo.
From my data I conclude that Xenopus Pex11β is essential for regulating
peroxisome number both in A6 cells in vitro and in vivo in embryos. Ectopic expression
in vivo demonstrated for the very first time Pex11β’s ability to induce peroxisome related
gene expression, and additionally to promote the early formation of peroxisome-like
structures in embryos.
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CHAPTER 3
MORPHOLINO-INDUCED KNOCKDOWN OF XENOPUS LAEVIS PEX11Β REVEALS ITS PIVOTAL
ROLE IN PEROXISOME BIOGENESIS DURING EMBRYONIC DEVELOPMENT.
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3.1 Introduction
3.1.1 Peroxisome overview
Peroxisomes are multifunctional single-membrane enclosed organelles that are
present in all eukaryotic cells. Peroxisomes house over 50 different matrix enzymes that
are linked to a diverse spectrum of metabolic activities, which can vary among different
species, developmental stages, and cell types (Delille, Dodt et al. 2011).

The

fundamental processes mediated by peroxisomes include reactions involved in lipid
metabolism; such as the synthesis of ether lipids, β-oxidation of very long chain fatty
acids (VLCFA), 2-methyl branched fatty acids, polyunsaturated fatty acids, and defense
systems for the in situ scavenging and elimination of peroxides, free radicals and other
reactive oxygen species (ROS) (Schrader and Fahimi 2006).
Peroxisomes are highly dynamic and capable of adapting to a variety of
environmental and developmental cues by altering their morphology, number and
enzyme content (Ma, Agrawal et al. 2011). The number and overall level of action of
peroxisomes is one of the mechanisms that regulate ROS levels in cells. High levels of
ROS levels are deemed detrimental to normal cellular functioning; whereas low ROS
levels may contribute to cell signaling, suggesting that peroxisome numbers and
functions must be tightly regulated. The biogenesis of peroxisomes is accomplished by
the coordinated activity of over 30 different peroxisomal matrix and peroxisomal
membrane proteins (PMPs) termed peroxins. Peroxins are nuclear encoded by Pex genes,
synthesized on free cytosolic polysomes and transported directly to peroxisomes or the
endoplasmic reticulum (ER) (Ma and Subramani 2009).
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3.1.2 Peroxisome biogenesis
Most PMPs are imported into the ER and then sorted into pre-peroxisomal
compartments in preparation for ER vesicle budding – a Pex3/Pex19 dependent process
(Ma, Agrawal et al. 2011). This de novo pathway is dependent on the ER, behaving as a
template for peroxisome biogenesis commonly referred to as the pre-peroxisomal
reticulum (Ma, Agrawal et al. 2011). These vesicles can then fuse with neighboring
vesicles forming mature functional peroxisomes. The alternate maturation pathway is
reliant on duplication of preexisting peroxisomes by fission and subsequent growth by
matrix protein import, a process mediated by cytosolic receptors Pex5 and Pex7 (Fujiki
2000). Matrix protein import is dependent on the recognition of two distinct peroxisometargeting signals (PTS). PTS-l is a conserved sequence of three amino acids (serinelysine-leucine) at the extreme C-terminus of most matrix proteins that are targeted to
peroxisomes by the Pex5 receptor. PTS-2 is a broad consensus nonapeptide sequence
(R/K-L-X5-Q/H/-L) found on matrix proteins at or near their N-terminus that are
recognized by the cytosolic Pex7 receptor. Both Pex5 and Pex7 deliver their respective
cargo to peroxisomes by docking with the peroxisomal importomer, a dynamic
peroxisomal translocon whose function is reliant on over 12 different peroxins, which
includes Pex1, an AAA-ATPase (Shiozawa, Maita et al. 2004). Functional peroxisomes
also contain PMP70 proteins, which are involved in the transport of long chain acyl-CoA
across the peroxisome membrane (Imanaka, Aihara et al. 2000).
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3.1.3 Peroxisome biogenesis disorders
In addition to their roles in metabolism and elimination of free radicals,
peroxisomal functioning is crucial to human development, as evident by the many
peroxisome biogenesis disorders (PDB). PDB’s such as the Zellweger syndrome
spectrum

(ZSS),

X-linked

Adrenoleukodystrophy

(ALD)

and

rhizomelic

chondrodysplasia punctata, are characterized by dysfunctional or lack of total
peroxisomes. Mutations in the Pex7 gene are responsible for the latter disorder, whereas
mutations in any one of many other Pex genes cause the ZSS and ALD disorders (Krause,
Rosewich et al. 2006).

3.1.4 Pex11-family of peroxins
The Pex11-family has received much interest with respect to ZSS due to their
ability to independently induce peroxisome proliferation. Pex11 proteins are unique
PMPs that directly participate in peroxisome divisions in yeasts (Li and Gould 2003),
plants (Orth, Reumann et al. 2007), mammals (Thoms and Erdmann 2005) and recently
amphibians (Fox, Walsh et al. 2011). In particular, Pex11β can induces peroxisome
proliferation via elongation of the existing peroxisomal membrane, followed by
constriction and final division via fission into peroxisomes (Li and Gould 2003). While
studies support a direct role for the Pex11β in peroxisome division in vitro, little is
known about its role during embryogenesis.
Most oviparous and many viviparous embryos depend on the rapid metabolism of
stored fuels early in their development to provide the energy for early embryonic events.
In addition to the metabolism of fatty acids, the metabolic activities of early embryos

	
  

98

generate a variety of ROS elements whose levels must be tightly regulated such that they
are not detrimental, but still available to play signaling roles. ROS levels have been
shown to be important in regulating various cellular processes and signaling cascades.
Nucleoredoxin, a thioredoxin related protein, was shown to inhibit Wnt-β-catenin
signaling through disheveled in Xenopus laevis (Funato and Miki 2010). X. laevis
development ⎯ whose early cell signaling cascades are well understood, and utilization
of yolk stores require peroxisome function with respect to both the breakdown of fatty
acids and the regulation of ROS levels ⎯ provides an excellent model with which to
examine the developmental roles of peroxisomes.

3.1.5 Hypotheses of Pex11β knockdown
I have previously shown that overexpression of Pex11β can increase the number of
peroxisomes in A6 cells in vitro, and induce an early-onset to peroxisome-like structures
during X. laevis embryogenesis in vivo (Fox, Walsh et al. 2011). In an effort to improve
our understanding of Pex11β, I have generated a Pex11β-morpholino (MO) to test the
hypothesis that knock down of Pex11β has the ability to decrease peroxisome related
gene and protein expression, and peroxisome numbers in both A6 cells and during X.
laevis embryogenesis. Our results demonstrated that knocking down Pex11β decreased
the number of peroxisomes in A6 cells in vitro, and resulted in modifications to the size
and distribution of peroxisomes during embryogenesis in vivo. Our data suggests, in
compilation with our previous findings, that Pex11β has a direct role in regulating
peroxisome biogenesis during X. laevis embryogenesis.
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3.2 Materials and Methods
3.2.1 Embryo Work
Adult X. laevis were reared in accordance with Canadian Council on Animal Care
regulations.

Fertilizations were performed according to Wu and Gerhart (Wu and

Gerhart 1991), and embryos were staged according to Nieuwkoop and Faber (Nieuwkoop
1973). Embryos to be sectioned were fixed in 3% formaldehyde at developmental stages
15 and 30.

Embryos were dehydrated, and infiltrated with paraffin wax for tissue

embedding and sectioning at Robarts Research Molecular Pathology Core Facility
(London, ON., Canada).

3.2.2 Microinjection and Morpholino Design
Morpholino oligos were injected using a Nanoject II (Drummond Scientific
Company). X. leavis embryos at the one-cell stage were injected with 2.3 nl of 400 μM
morpholino (MO) oligos. Design and synthesis of morpholinos was performed by Gene
Tools (Gene Tools, Philomath, USA). Morpholinos were engineered as translationblocking

targets

against

X. laevis Pex11β

CGCTGAACCGAACCCACGAGTCCAT].

[GenBank:MGC69071],

[antisense

Additionally, a carboxyfluoresceinated

morpholino oligos targeted to X. laevis β-catenin gene were purchased as a prepared
control oligo from Gene Tools [antisense TTTCAACCGTTTCCAAGAACCAGG].
Each morpholino was used in at least three independent experiments and injected each
time at three different concentrations (400, 600 and 800 μM).

	
  

100

3.2.3 Cloning, RNA Synthesis, and Microinjection
We cloned Xenopus full length Pex11β [GenBank:MGC69071] from total adult
liver cDNA using specific primers using and SuperScriptTM Reverse Transcriptase
(Invitrogen) with Platinum® Taq DNA Polymerase High Fidelity (Invitrogen) using
conditions supplied by the manufacturer. A 5’ HA tag was added to Pex11β using
specific primers; HA-Pex11β 5’AGA TCT TCA AGC GTA ATC TGG TAC GTC GTA
TGG GTA GGG CTT CAG CTT CAG CCA 3’ and 5’ CGA ACC CAC GAG TCC ATA
CTA GT 3’. We also engineered GFP tagged with the PTS1 SKL, using forward 5’ AGA
TCT ATG GTG AGC AAG GGC GAG 3’ and 5’ ACT AGT CTA TAA TTT GGA CTT
GTA CAG CTC GTC CA 3’. PCR products were cloned into the pCR®II-TOPO vector
as per manufacturer’s instructions (Invitrogen). Recombinant sequences were confirmed
at the Robarts Research Institute DNA Sequencing Facility at the University of Western
Ontario. Desired clones were additionally cloned into pcDNA™TOPO 3.3® TA Cloning
Kit (Invitrogen) for cell culture experiments, and T7TS plasmid and sequenced in vitro
RNA production.

Capped polyadenylated RNA was synthesized using mMachine

mMessage® T7 (Ambion) and visualized on a 1.0% agarose formaldehyde gel to ensure
quality and transcription validity. Embryos at the one-cell stage in 4% ficoll in 1X Marks
Modified Ringer (MMR) solution were microinjected with approximately 1 ng of desired
RNA. Following 4 hours, embryos were transferred to 0.1X MMR for rearing.

3.2.4 Cell lines, Transfections and Immunocytochemistry
A6 cells derived from X. laevis epithelial cells (generous gift from Dr. John
Heikkila, University of Waterloo, ON) were grown in Leibowitz-15 media (with 10%
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FBS and 1% penicillin and streptomycin) at room temperature. All transfections were
completed using Neon Transfection System (Invitrogen) performed according to the
manufacturer's protocol with two pulses of 1250 V and 20 ms. For immunofluorescence,
cells were fixed in 3.7% formaldehyde in Dulbecco's modified PBS (DPBS) (Invitrogen),
pH 7.2, for 15 min, and permeabilized in 1.5% Triton X-100 in DPBS for 10 min. Cells
were incubated with either PMP70 (Abcam, ab4965) or Catalase (Cedarlane), polyclonal
antibodies for 5 hours, washed three times in PBST for 10 minutes each, incubated with
fluorescently labeled secondary antibodies for 1 hour, washed again for 5 minutes in
DPBS, and mounted on slides using ProGold Mounting Media (Invitrogen). Samples
were visualized with a Zeiss AxioStop 2 Mot. Images were captured with a Retiga 1600
camera (Qimaging) and fluorescence quantifications were completed using Northern
Eclipse image capture and analysis software (Empix).

3.2.5 RNA Isolations and Reverse Transcriptase PCR (RT-PCR)
RNA was isolated from A6 cell lysates two days following transfections, and total
RNA was isolated from embryos at developmental stages 15, 30, 45, with an RNeasy kit
(QIAGEN), both of which were evaluated on a 1.0% agarose formaldehyde gel.
Synthesis of cDNA was completed with SuperScript II Reverse Transcriptase
(Invitrogen) following manufactures protocol. To analyze RNA expression levels during
development, RT-PCR primers were designed against known X. laevis peroxisomal and
PPAR genes with the following accession numbers: Pex3 [EMBL:AAH73069.1], Pex5
[NP_001011381],
[BC054964]

Pex11β

Pex1

[GenBank:MGC69071],

[NM_001091972.1],

PPARα

PMP70

[EF07060],

Catalase

[NM_001095362],

PPARδ
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[NM_001087841], and PPARγ [NM_001087843]. Mid-log phase RT-PCR products
were visualized on a 0.8% agarose gel and unsaturated band intensities were quantified
against control elongation factor-1α (EF1α) [NCBI: NM_001087442] using Quantity
One software (Version 4.4.0 Bio-Rad). All quantified PCR reactions were completed in
triplicate. The amplicons of peroxisomal genes listed above were cloned with the TOPOTA Cloning® (Invitrogen) system as described by the manufacturer's protocol and
sequenced to ensure gene identities.

3.2.6 Western Blot Analysis
Pex11β (Abcam, ab74507), β-catenin (Invitrogen), PMP70 (Abcam, ab4965),
Catalase (Cedarlane), and β-actin (Invitrogen) polyclonal antibodies were used to detect
protein from both X. laevis A6 cell and embryonic lysates before and after treatments.
Bradford protein quantifications were used to ensure that equivalent amounts of protein
(13 mg) were loaded for each sample [34]. Primary antibodies were used in a 1 in 5000
dilution and secondary 1 in 8,000 dilution, and blots were developed using an enhanced
chemiluminescence kit (Amersham). Band intensities were quantified using Quantity
One software (Version 4.4.0 Bio-Rad).

3.2.7 Immunohistochemistry
Paraffin-embedded embryo sections were washed in xylene and re-hydrated by
washing in 100, 90, 80, and 65% ethanol each for 10 minutes twice, followed by 10 min
in 0.1% Tween-20 in PBS three times.

Histology sections to be immunostained were

incubated with a 24-hour primary, followed by a two-hour secondary (FITC conjugated)
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antibody incubation in a 1 in 400 antibody dilution. Embryos were counterstained with
DAPI (Invitrogen) according to the manufacturer's protocol. Images were captured and
fluorescence quantified with a Zeiss LSM Dou (Live 5 Vario II and 510 Meta) Confocal
system using Northern Eclipse image capture and analysis software (Empix).

3.2.8 Statistical Analyses
Tests of significance are described within the legend of the figure as required.
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3.3 Results
3.3.1 Knockdown of Pex11β altered peroxisome related gene expression in X. laevis A6
cells.
To study the effects of reduced levels of Pex11β during X. laevis embryogenesis
we first investigated if knockdown of Pex11β could alter the RNA levels of the
peroxisome related genes Pex1, -3, -5, -11β, Catalase, PMP70, PPARα, -δ, and -γ in X.
laevis A6 kidney epithelial cells. A6 cells were transfected with a translation start-site
blocking morpholino oligonucleotides designed to knockdown Pex11β protein levels.
Cells were transfected with full-length GFP DNA as a control. Semi-quantitative RTPCR analyses revealed a significant decrease in PMP70 and Pex1 mRNA levels, and a
significant increase in PPARγ mRNA levels, following transfection of Pex11β-MO
(Figure 3.1). No significant changes were found in levels of Pex11β, Catalase, Pex3, -5,
PPARα nor in PPARδ mRNA. Levels are displayed relative to EF1α expression (Figure
3.1).

3.3.2 Knockdown of Pex11β in X. laevis A6 cells decreased PMP70 protein levels.
Since knockdown of Pex11β decreased mRNA for PMP70, we wanted to
determine if there were actual decreases in the relative protein levels for this hallmark
peroxisomal protein, that is found in functional peroxisomes. A6 cells were transfected
with morpholino oligonucleotides designed to knockdown either Pex11β or β-catenin
protein levels, or cells were transfected with full-length GFP DNA as a control. Pex11β
and β-catenin specific antibodies confirmed bands of expected sizes for both Pex11β (63
kDa) and β-catenin (94 kDa), and confirmed the efficacy of each morpholino (Figure
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3.2A) as they reduced their respective protein levels. Western blot analysis for Catalase
revealed bands of expected sizes (55 kDa), but Catalase levels were unchanged following
knockdown of Pex11β (Figure 3.2A). However, Western blot analysis for PMP70, which
revealed bands of expected sizes for PMP70 (70 kDa), did display a significant decrease
in PMP70 protein levels with Pex11β-MO versus both β-catenin and GFP controls
(Figure 3.2A, left three GFP lanes versus middle three Pex11β-MO lanes versus right
three β-catenin lanes, and quantified in Figure 3.2B. The use of β-actin (41 kDa) specific
antibodies confirmed the relative protein levels in each lane (Figure 3.2A).
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Figure 3.1. Pex11β morpholino altered peroxisome related gene expression in X.
laevis A6 cells. RT-PCR analysis was performed using RNA isolated from A6 cells
transfected with Pex11β-MO or GFP (control) DNA. Two days following transfection
reverse-transcribed cDNAs were subject to PCR amplification using primers specific to
peroxisomal genes; Pex11β, PMP70, Catalase, Pex5, Pex3, Pex1, PPARα, -δ, and -γ.
The respective transcript levels represent measures of mid-log phase RT-PCR product
band intensities, relative to levels of EF1α. Genes whose levels were altered significantly
as assessed by a paired sample t-test are denoted with an asterisk (*). PMP70 and Pex1
displayed reduced levels of expression following treatment, while PPARγ displayed
increased expression. P<0.05, n=3. Values presented are the means ± SE.
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Figure 3.2. Pex11β morpholino decreased PMP70 protein levels in X. leavis A6 cells.
(A) Western blot analysis revealed decreased proteins levels of PMP70 and Pex11β
following transfection of Pex11β-MO. Levels of these proteins remained unchanged in
cells transfected with GFP DNA or β-catenin MO (A). Pex11β and β-catenin antibodies
confirmed the efficiency of both the Pex11β-MO and β-catenin-MO versus GFP DNA
control transfections. Catalase protein levels were unaffected by neither Pex11β-MO nor
β-catenin-MO. Protein loading in each lane was confirmed and standardized via a βactin antibody. (B) Western blot signals were digitized and data were quantified and
analyzed to statistically compare protein levels. There was a significant decrease in the
levels of Pex11β and PMP70 protein following transfection of Pex11β-MO, but not with
β-catenin-MO or GFP DNA. Additionally, there was a significant decrease in the levels
of β-catenin following transfection of β-catenin-MO versus Pex11β-MO and GFP control
cells. There was no significant change in the levels of Catalase. Statistical relevance of
discrepancies between groups (asterisks) was assessed by a paired sample t-test. P<0.05,
n=3. Values presented are the means ± SE.

	
  

109

	
  

110

3.3.3 Knockdown of Pex11β in X. laevis A6 cells decreased the number of PMP70positive peroxisome-like structures.
To determine whether knockdown of Pex11β has an effect on peroxisome-like
structures and numbers we examined the effects of knocking down Pex11β in X. laevis
A6 cells using immunocytochemistry. One day following transfection, A6 cells were
fixed and probed with Catalase and PMP70 specific antibodies. Immunocytochemistry
allowed us to examine the distribution of both Catalase and PMP70 protein, and to
quantify their relative protein levels using a fluorescently conjugated secondary antibody.
Consistent with our Western blot analysis our results indicated that knockdown of
Pex11β significantly decreased the number of PMP70-positive punctate spots (Figure
3.3D versus E). Quantifying the relative levels of indirect fluorescent for PMP70
demonstrated that levels decreased >1.5 fold (Figure 3.3F). The Pex11β-MO had no
effect on the number Catalase-positive punctate spots (Figure 3.3A versus B).
To ensure that decreases in PMP70 levels were in fact representative of
peroxisomes, we tested whether knockdown of Pex11β could also alter the distribution of
the peroxisome maker GFP-SKL. We have previously shown that GFP-SKL in X. laevis
will localize as punctate-like structures indicative of peroxisomes (Fox, Walsh et al.
2011). A6 cells were co-transfected with Pex11β-MO and GFP-SKL, or GFP-SKL
alone. One day following transfections, punctate-like structures were visualized by direct
immunofluorescence.

Our results indicate that the number of GFP-SKL containing

bodies decreased in cells that were transfected with Pex11β-MO versus GFP-SLK alone
(Figure 3.3G versus H). These results were quantified and shown to decrease >2.5 fold
(Figure 3.3I).
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Figure 3.3. Pex11β morpholino altered PMP70 distribution in X. laevis A6 cells. A,
D, and G are untransfected cells, while B, E, and H are transfected with Pex11β-MO. G
and H were additionally co-transfected with GFP-SKL. Using identical imaging and
photography parameters, indirect immunofluorescence using a Catalase antibody
revealed no difference of signal in untransfected cells (A) versus those containing the
Pex11β-MO (B). However, indirect immunofluorescence using a PMP70 antibody
revealed a lower number of immunofluorescent signals in transfected cells (E) versus
untransfected (D) cells. Direct fluorescence for GFP revealed a punctate signal from
GFP-SKL in untransfected cells, (G) versus a more diffuse GFP staining patterns in
Pex11β-MO transfected cells (H). The relative fluorescence intensity in 10 regions of
twenty-five randomly imaged cells was quantified using Northern Eclipse software.
Graphs on the right represent the average fluorescence intensity of non-transfected versus
Pex11β-MO transfected cells. Values presented are the means ± SE. Significance at
P<0.05 was determined using Student’s t-test, n=25.
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3.3.4 Pex11β decreased peroxisome related gene expression during X. laevis
embryogenesis.
To test our hypothesis that knockdown of Pex11β has a direct role in regulating
peroxisome biogenesis during embryogenesis, we next examined the effects of decreased
Pex11β in vivo, by investigating changes in expression of peroxisome related genes
following the microinjection Pex11β-MO into early X. laevis embryos. The temporal
expression of five peroxisomal genes were first analyzed during developmental stages 15,
30 and 45.
With the exception of Pex5, all peroxisomal genes examined in control embryos
increased in expression as development progressed with their lowest expression levels at
stage 15 followed by increasing levels from stages 30 to 45. (Figure 3.4, significance
between stages denoted by double asterisks). Pex11β, PMP70 and Pex1 were found to
significantly increase between developmental stages 15 versus 45 and 30 versus 45
(Figure 3.4, double asterisks). Pex3 was found to significantly increase between all three
stages examined (Figure 3.4, double asterisks) and Catalase was found to significantly
increase between developmental stages 15 versus 30 and 30 versus 45 (Figure 3.4, double
asterisks).
Following microinjection of Pex11β-MO there were significantly decreased RNA
levels of PMP70 and Pex1 at stages 15, 30 and 45 (Figure 3.4, single asterisk) versus the
control RNA levels for each gene.

Microinjecting Pex11β-MO also resulted in

significant decreases of Pex3 at stages 15 and 30, as well as Pex11β at stage 45. There
were no significant changes in Pex11β at stages 15 or 30 nor Catalase at stages 15, 30
and 45 following microinjecting Pex11β-MO.
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Figure 3.4. Pex11β morpholino reduced Pex11β, Pex3, and PMP70 RNA levels in X.
laevis embryos. The respective bar heights represent measures of mid-log phase RTPCR product band intensities, relative to levels of EF1α. RT-PCR analysis during normal
embryogenesis revealed that the levels of all genes examined, with the exception of Pex5,
increased as development progressed from stage 15 to 30 to 45. A repeated measures
ANOVA was carried out comparing RNA levels at all 3 stages of control embryos. When
significant, a paired sample t-test was carried out between levels at a given stage in
control embryos. Significant changes in RNA levels of a gene between stages is
represented by the double asterisk ** (P<0.05). Pex3 expression levels differed between
all stages, 15 versus 30, 30 versus 45 and 15 versus 45. Catalase levels differed at stages
15 versus 30 and 15 versus 45 but NOT between 30 versus 45. For Pex11β and Pex1
there are differences between stages 30 versus 45 and 15 versus 45 but NOT between 15
versus 30. As the means were correlated, a MANOVA was carried out on the means of
the treatment and control groups at each stage to see whether there were differences in
the RNA level of each gene at a given stage, in the presence of the Pex11β morpholino.
As the MANOVA showed a significant effect of condition, a Wilks lambda analysis was
used, and the univariate ANOVAs showed the Pex11β morpholino resulted in
significantly lower levels of gene expression, as represented by the single asterisk *
(P<0.05). PMP70 and Pex1 displayed significant decreased RNA levels stage 15, stage
30 and stage 45. Pex3 displayed decreased levels at stages 15 and 45, while Pex11β
displayed decreased expression only at stage 45. n=3. Values presented are the means ±
SE.
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3.3.5 Embryonic knockdown of Pex11β decreased PMP70 protein levels at
developmental stage 15.
We next wanted to determine if knockdown of Pex11β had an effect on our
hallmark peroxisome related protein PMP7, in vivo, similar to our in vitro data.
Fertilized embryos were microinjected with Pex11β-MO, β-catenin-MO or full length
GFP mRNAl. Protein extracts were taken at developmental stage 15 and purified for
Western blot analysis. Pex11β and β-catenin specific antibodies confirmed bands of
expected sizes for both Pex11β (63 kDa) and β-catenin (94 kDa), and confirmed the
efficacy of each morpholino in vivo (Figure 3.5A) as they reduced their respective protein
levels. Catalase (55 kDa) levels were found unchanged following microinjection of
Pex11β-MO, β-catenin-MO or GFP (Figure 3.5A). However, Western blot analysis for
PMP70 (70 kDa) revealed a decrease in PMP70 protein levels with of Pex11β-MO
relative to both β-catenin-MO and GFP (Figure 3.5A, left GFP lane versus middle
Pex11β-MO lane versus right β-catenin lane, and quantified in Figure 3.5B). This
decrease in PMP70 levels was also seen when the Western blot data was digitized and
examined graphically. The use of β-actin (41 kDa) specific antibodies confirmed the
relative protein levels in each lane (Figure 3.5A). A representative blot is shown, though
repeated experiments showed consistent results.
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Figure 3.5. Pex11β morpholino decreased PMP70 protein levels in X. laevis
embryos. (A) Following the microinjection of a Pex11β-MO at the one cell stage,
Western blotting revealed decreased proteins levels of Pex11β and PMP70 proteins in
stage 15 embryos. No change Pex11β and PMP70 protein levels was seen in control GFP
DNA or β-catenin-MO injected embryos. Pex11β and β-catenin antibodies confirmed
the efficiency of both Pex11β-MO and β-catenin-MO reagents. Catalase protein levels
were unaffected by Pex11β-MO, β-catenin-MO and GFP injections. Protein loading in
each lane was confirmed via a β-actin antibody. (B) Western blot signals were digitized
and data were quantified relative to β-actin levels. A representative blot is shown, though
repeated experiments showed consistent results.
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3.3.6 PMP70 antibodies revealed a later accumulation of punctate structures during X.
laevis embryogenesis following injection of Pex11β-MO.
In order to determine if knockdown of Pex11β could reduce peroxisome-like
structures during development, we used immunohistochemistry to visualize changes in
the embryonic distribution of Catalase and PMP70, in response to microinjecting
Pex11β-MO.

Fertilized embryos were microinjected with Pex11β-MO and fixed at

stages 15 and 30, and sectioned for immunohistochemical analysis. Catalase and PMP70
signals were present at very low levels at stage 15 under control conditions (Figure 3.6A
and 3.7A). Punctate structures were visible within the somites of control embryos at
stage 30 using Catalase (Figure 3.6B), and PMP70 (Figure 3.7B) specific antibodies. The
linear organization of the DAPI stained nuclei is a typical feature seen during of X. laevis
somite differentiation. Following microinjection of Pex11β-MO, Catalase signals
remained largely unchanged, with very few punctate signals seen at stage 15 increasing in
number by stage 30, similar to the control embryos (Figure 3.6A versus C and 3.6B
versus D).
However, following the microinjection of Pex11β-MO, PMP70 signals were
altered. While the relatively few PMP70 specific signals at stage 15 were not different
between the control and Pex11β-MO injected embryos (Figure 3.7A versus C) there is a
difference in the number of punctate signals at stage 30 with few being present in
embryos that have been injected with Pex11β-MO.
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Figure 3.6. Pex11β morpholino had no affect on Catalase immunofluorescence in
stage 15 and 30 somites in X. laevis embryos. Both control (A and B) and Pex11β-MO
injected (C and D) embryos at developmental stages 15 (A and C) and 30 (B and D),
were fixed then sectioned for immunohistochemical analysis in somties.

Using a

Catalase antibody, punctate structures were detected at stage 15 and 30 under control
conditions (A and B) and following microinjection of Pex11β-MO (C and D). There was
no difference in the number or pattern of the signal between control and morpholino
injected embryos. Identical imaging and photography parameters were used for all
images. DAPI (blue), PMP70 (green). The linear arrangement of the stage 30 somitic
nuclei is typical in X. laevis. Images were taken at 60x.
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Figure 3.7. Pex11β morpholino decreased PMP70 immunofluorescence in stage 15
and 30 somites in X. laevis embryos. Both control (A and B) and Pex11β-MO injected
(C and D) embryos at developmental stages 15 (A and C) and 30 (B and D), were fixed
then sectioned for immunohistochemical analysis in somites. Using a PMP70 antibody
punctate structures are detected at stage 15 and 30 in somitic mesoderm of uninjected
embryos (A and B). In embryos that had been injected at the one cell stage with Pex11βMO, the PMP70 antibody signal decreased at stage 15 and 30 (C and D) compared to the
control. Identical imaging and photography parameters were used for all images. DAPI
(blue), PMP70 (green). The linear arrangement of the stage 30 somitic nuclei is typical
in X. laevis. Images were taken at 60x.
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3.3.7 Knockdown of Pex11β induced a change in peroxisome distribution and size
during X. laevis somite maturation.
Next, we wanted to determine if knockdown of Pex11β had an effect on
peroxisome number or peroxisome biogenesis. Fertilized embryos were microinjected
with GFP-SKL alone, or co-injected with Pex11β-MO and GFP-SKL, were fixed at
stages 15 and 30, and sectioned for immunohistochemical analysis. We used direct
immunofluorescence to visualize the affects of Pex11β-MO on the localization patterns
of GFP-SKL. In the absence Pex11β-MO GFP-SKL resulted in few punctate signals at
stage 15 (Figure 3.8A), but the number of distinct punctate signals increased at stage 30
(Figure 3.8B), and were reminiscent of those seem at this stage by Catalase (Figure 3.6B)
and PMP70 (Figure 3.7B). However, Pex11β-MO resulted in the presence of large
diffuse GFP-SKL-containing bodies at stage 15 and 30 (Fig 3.8A and B versus 3.8C and
D). These structures were more prevalent and more abundant at stage 15 versus 30
(Figure 3.8C versus D).
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Pex11β morpholino altered the size and distribution of GFP-SKL-

positive structures in stage 15 and 30 somites in X. laevis embryos. Embryos injected
at the one cell stage with GFP-SKL alone (A and B) or with GFP-SKL and Pex11β-MO
(C and D) were both reared to developmental stages 15 (A and C) and 30 (B and D), and
then fixed and sectioned for immunohistochemical analysis. Using a GFP antibody
punctate structures are detected in control embryos at stage 15 and 30 (A and B). In
embryos that had been injected at the one cell stage with Pex11β-MO the GFP antibody
signal was stronger and more widely distributed (A vs C). By stage 30 the GFP antibody
signal had decreased compared to stage 15, but was still more prevalent and widely
distributed than in embryos that have not be injected with the Pex11β-MO (B vs D)
punctate GFP structures numbers decreased with an increase in diffuse GFP staining.
Identical imaging and photography parameters were used for all images. DAPI (blue),
PMP70 (green). The linear arrangement of the stage 30 somitic nuclei is typical in X.
leavis. Images were taken at 60x.
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3.4 Discussion
3.4.1 Role of Pex11 in peroxisome biogenesis
Our recent understanding that ROS moieties can play important roles in cell
signalling has brought new attention to organelles such as peroxisomes as they could
have important developmental roles. Peroxisomes can arise from the ER as preperoxisomal compartments, which bud off in a Pex3/Pex19 dependent manner, utilizing
the ER as a template for de novo biogenesis. These vesicles then form mature
peroxisomes by fusion with neighboring peroxisomes, or by matrix protein import
mediated by cytosolic chaperones Pex5 and Pex7. In addition to ER de novo biogenesis,
there is also evidence that peroxisomes can arise from the budding of pre-existing
peroxisomes (South and Gould 1999). Duplication of preexisting peroxisomes by fission,
growth and maturation is the major pathway for proliferation facilitated by Pex11 and a
specific set of dynamin related proteins (DRPs) (Thoms and Erdmann 2005). In addition,
other molecules and mechanisms have been shown to regulate peroxisome abundance
such as PPARγ, shown to play important roles in peroxisome biogenesis. PPARγ also
regulates a variety of other peroxisome-independent metabolic processes, where as
Pex11β functions seem limited to peroxisome biogenesis.
The key hypotheses tested here is that undifferentiated embryonic cells have no or
low levels of peroxisomes which are needed as cells differentiate, and that Pex11β plays
a key role in regulating their embryonic abundance. This would be particularly true in
differentiating cells that are highly metabolic, such as developing X. laevis somites.
While there are few reports that specifically describe the lack of peroxisomes in
undifferentiated or stem cells, several studies do describe an increase in peroxisome

	
  

128

numbers as cells differentiate. Studies using hair follicle stem cells (Karnik, Tekeste et al.
2009), epidermal side population with stem cell-like characteristics (Carr, OberleyDeegan et al. 2011), embryonic stem cells (Kuai, Cong et al. 2006; Ostadsharif, Ghaedi et
al. 2011), intestinal immature stem cells (Phipps, Connock et al. 2000), all demonstrate
that peroxisomal numbers increase as these stem cells differentiate. Further, using a GFPtagged peroxisomal marker, we recently reported that peroxisomes are not detectable in
early X. laevis somites (Fox, Walsh et al. 2011). This data is supported by other
embryological work that shows that peroxisomes are detected at low levels in human and
rat trophoblast and other extraembryonic tissues where their numbers increased with
gestation (Phipps, Connock et al. 2000).

3.4.2 Reduced protein levels of Pex11β in vitro reduced peroxisomal structures
As we have previously shown that ectopic expression of Pex11β during frog
embryogenesis resulted in the early presence of peroxisomes, we sought to examine the
effects of decreasing embryonic Pex11β levels.

A X. laevis translation blocking

morpholino was shown through Western blot analysis to reduce Pex11β protein levels,
along with the use of a control β-catenin-MO, when used in both A6 cells and embryos.
We demonstrated a decrease in PMP70 and Pex1 RNA levels, followed by an
increase in PPARγ RNA levels after transfection of Pex11β-MO in A6 cells. The
decrease in PMP70, and unchanged Catalase levels, was confirmed at the protein level by
Western blot analysis, and visualized using immunocytochemistry. Together, these data
suggest that reduced Pex11β levels decreased the PMP70 protein, and the number of
PMP70-positive vesicles, but not the levels of Catalase. This reduction in the number of
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PMP70-positive vesicles could be due to the reduction of fission, due to reduced Pex11β
levels, from preexisting peroxisomes.

The level of Catalase, which also functions

independent of peroxisomes in the cytoplasm, was unaffected. Increases in PPARγ and
Pex1 RNA levels further suggest that cells are compensating for reduced peroxisomal
numbers by increasing their rate of metabolism, through PPARγ, and increasing their
peroxisome maturation, through Pex1 (Gould and Valle 2000).

3.4.3 In vitro changes in protein levels of Pex11β are also seen in vivo
As knockdown of Pex11β was able to reduce the number of PMP70-positive
vesicles in differentiated epithelial A6 cells, we next sought to examine the effects of
reduced Pex11β levels in early stage X. leavis embryos where cells are differentiating.
As with our previous study we focus on the developing somites – cells that are
metabolically active and easy to identify. Knockdown of Pex11β in embryos, as in A6
cells, reduced Pex1 and PMP70 RNA levels, while Pex5 and Catalase RNA levels
remained unchanged. Pex3 RNA levels are reduced significantly in embryos, though this
reduction was not significant in A6 cells. At the protein level Pex11β and PMP70 protein
levels decreased, with no changes in Catalase, consistent with our cell culture data.
These relative changes in protein levels were also visible at stage 15, and stage 30
somites using immunohistochemistry.

A Catalase specific antibody showed no

difference in the number of Catalase-positive punctate structures at stage 15, nor stage 30
somites in Pex11β morpholino injected embryos. However, Pex11β knockdown resulted
in a decreased number of punctate PMP70-specific structures at both stages 15 and 30.
As this altered distribution of PMP70 structures suggested a decrease in the number of
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peroxisomes, a GFP-SKL reporter that is capable of being imported into peroxisomes
was used. The import of GFP-SKL is likely to involve Pex3 and -19, and not PMP70.
The GFP-SKL reporter revealed the presence of large organelle structures following
Pex11β morpholino injections, particularly at stage 15. These organelles were distinct
from the ones seen with the PMP70 antibody. The decreased number of PMP70 positive
organelles in response to lower Pex11β levels could be due to incomplete fission of
existing peroxisomes, which would require Pex11β. Thus the larger organelles represent
immature peroxisomes that await fission and import of other peroxisomal components,
such as PMP70. As development continued from stage 15 to 30 budding of peroxisomes
occurred at a slower rate, and thus more PMP70 punctate signals are present at stage 30
than 15. Catalase, which is known to have functions independent of peroxisomes, is not
affected by this change in peroxisome numbers.
These results showed that Pex11β played an important role during embryogenesis
to regulate peroxisome numbers, key metabolic processes, overall ROS levels and thus
cell signalling pathways. Pex11β deficiency in mice is lethal (Li, Baumgart et al. 2002),
where the deletion of both alleles caused a 30% reduction in peroxisome number in brain
and the deletion of only one allele resulted in altered SOD2 levels, but not Catalase levels
(Ahlemeyer, Gottwald et al. 2011). Thus Pex11β can control embryonic peroxisome
numbers, and can regulate specific metabolic genes, but not Catalase.
We have previously demonstrated that an increase in Pex11β resulted in increases
in both Catalase and PMP70. With Pex11β acting as a regulator of peroxisome numbers,
as numbers increased there was an embryonic response to also increase Catalase and
PMP70 protein levels (along with other peroxisomal proteins). However in this study,
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when Pex11β levels decreased, cellular responses are different, as seen by the distinctive
localization of GFP-SKL, and the delay in the accumulation of mature PMP70 containing
organelles. This suggests that cellular responses to such perturbations are specific and
vital as these embryonic cells attempt to maintain crucial levels of metabolism and ROS
signalling to allow their proper differentiation.

3.4.5 Concluding remarks
In conclusions, this study suggests that X. laevis Pex11β has a pivotal role in the
regulation of peroxisome biogenesis in both A6 cells in vitro, and during embryogenesis
in vivo. Morpholino-induced knockdown of Pex11β demonstrated that Pex11β a key
regulator in biogenesis contributes to the regulation of peroxisome number during X.
laevis embryogenesis.
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CHAPTER 4
PEROXISOME NUMBERS DIRECTLY AFFECT LEVELS OF ROS AND THE REDOX-SENSITIVE
MECHANISM OF WNT/PCP CELL SIGNALING
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4.1. Introduction
4.1.1 Peroxisome overview
Peroxisomes are membrane-bound organelles that are primarily involved in
the oxidation of fatty acids and the biosynthesis of plasmalogens, an ether-linked
phospholipids involved in the myelination of nerve cells.

As a byproduct of

metabolism, these organelles generate a variety of reactive oxygen species (ROS),
which can be harmful to various biological processes. To compensate for such high
levels of ROS, peroxisomes contain an array of antioxidant defense enzymes, which
are involved in the detoxification of these deleterious molecules. Imbalance in ROS
levels can be damaging to cellular constituents and potentially deregulate redoxsensitive cell signaling pathways implicated in a variety of cell and developmental
processes (Antonenkov, Grunau et al. 2010).
The purpose of this chapter is to determine whether or not changes in peroxisome
numbers can modify ROS levels, thereby resulting in altercations to redox-sensitive cell
signaling. Specifically, we are examining if altered ROS levels have an effect on Wnt
signaling in Xenopus laevis A6 cells. It has been previously demonstrated that the redox
mechanisms of Wnt signaling are sensitive to ROS during X. laevis development (Funato,
Michiue et al. 2008). This research, however, examines for the first time the relationship
between peroxisome numbers and cellular ROS levels as a factor effecting redoxsensitive Wnt signaling.
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4.1.2 Peroxisomal ROS and its relation to the cellular redox state
Little attention has been directed to the importance of peroxisomes in the
maintenance of cellular ROS levels. Recently, peroxisomal ROS metabolism and its
relationship to cell signaling has become an exciting and rapidly evolving
multidisciplinary research field, with important implications for both development and
disease (Schrader and Fahimi 2006; Bonekamp, Volkl et al. 2009). For instance, human
patients suffering from an inherited deficiency in catalase (the hallmark peroxisomal
antioxidant) have an increased risk of developing age-related diseases including diabetes,
atherosclerosis, and cancer (Goth and Eaton 2000).

Additionally, the absence of

functional peroxisomes caused increased apoptosis in the developing mouse cerebellum,
which was predicted to be a result of increased levels of ROS (Krysko, Hulshagen et al.
2007). These observations and others shed light on the relationship between peroxisome
function and cellular ROS levels.
Of significant interest is the relationship between peroxisome number and the
cellular oxidation state. Cellular aging compromises the import of peroxisome targeting
signal 1 (PTS1) matrix proteins, affecting in particular, import of the antioxidant catalase
(Legakis, Koepke et al. 2002). In addition, the overall number of peroxisomes was
shown to drastically increase during cellular senescence, (Legakis, Koepke et al. 2002), a
process associated with increased systemic oxidative stress (Muller 2009).
It was suggested that cellular senescence may correspond to the regulation of
peroxisome size and number. As mammalian cells senesce, peroxisomes were found to
increase in size, suggesting a relationship between aberrant peroxisome function, aging
and oxidative stress (Legakis, Koepke et al. 2002). There is also substantial evidence that
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peroxisome number and morphology can drastically change upon exposure of cells to
various conditions of oxidative stress. For example, depletion of cellular glutathione
(GSH), a non-enzymatic antioxidant, results in peroxisome elongation in mammalian
cells (Schrader and Fahimi 2006). These data suggest that changes in peroxisome shape,
size and number respond to changes in ROS and are involved regulating cellular ROS
levels.

4.1.3 Hydrogen peroxide as a signaling molecule
Peroxisomes are organelles that both produce and break down hydrogen
peroxide (H2O2).

The latter is accomplished by catalase, which catalyzes the

decomposition of H2O2 into molecular oxygen and water. While catalase has been
extensively characterized as a molecular guardian of H2O2, many studies have
revealed the role of H2O2 as a signaling molecule. Among the various ROS produced,
H2O2 is the most abundant as it is present at an in vivo concentration of 10-7 M, and
has the longest half-life (t½ = 10-5s) (Paulsen and Carroll 2010). The relative stability
and uncharged nature of H2O2 permits enhanced diffusion across long distances and
membranes.

H2O2 has been shown to act as a paracrine signal in plant cell

differentiation (Bienert, Schjoerring et al. 2006), and more recently, in the
recruitment of immune cells to wound sites in zebrafish larvae (Niethammer,
Grabher et al. 2009). H2O2 is quickly generated in peroxisomes and the cytosol, and
these and other aforementioned properties make it an ideal mediator of signal
transduction processes.
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4.1.4 Redox signaling through protein thiol oxidation
It is well known that the reversible phosphorylation of kinases, phosphatases and
transcription factors functions as a switch to modulate protein activity. ROS are well
known regulators of a variety of cell signaling pathways through their ability to oxidize
and modulate protein activity. An important cellular sensor of ROS is the thiol (SH)
functional group of the amino acid cysteine (Cys). SH groups have a number of
oxidation states resulting in the generation of sulphenic acid (SOH), sulphinic acid
(SO2H), sulphonic acid (SO3H) or the formation of disulphide bonds (R-S-S-R) within a
protein itself or with a neighboring protein. Similar to phosphorylation, these various
degrees of oxidation function as a switch for modulating protein activity.
A variety of important macromolecules are sensitive to redox modifications by
ROS including extracellular matrix molecules, phosphatases, kinases and a number of
transcription factors. As a result, many cell signaling pathways have been distinguished
as redox sensitive. Of the well documented examples, the Wnt signaling pathway was
first identified as redox sensitive in X. laevis embryos (Funato, Michiue et al. 2008).

4.1.5 Redox regulated Wnt signaling
Wnts are a family of ligands that are utilized in normal development, and
contribute to cellular processes such as differentiation, proliferation and pattern formation
(Clevers 2006). Biochemical analyses have revealed that Wnt signaling can occur via
several branches of Wnt related pathways. The first identified Wnt pathway, referred
to as the canonical Wnt or Wnt/β-catenin pathway, results in the cytosolic
accumulation and subsequent nuclear localization of β-catenin, and the transcription
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of specific genes with the aid of T-cell factor/lymphoid enhancing factor (Tcf/Lef).
Specifically, Wnts bind to the cell surface receptor, Frizzled (Fzd), which activates
Dishevelled (Dvl), to inhibit a group of proteins termed the destruction complex, thereby
resulting in the cytoplasmic accumulation of β-catenin. Recent studies on Wnts in X.
laevis indicate a redox sensitive switch for this pathway.

It was determined that

nucleoredoxin (Nrx), a thioredoxin (Trx) related protein, may play a regulatory role in
canonical Wnt signaling by directly controlling Dvl activity (Funato, Terabayashi et al.
2010). Nrx binds to Dvl in its reduced form suppressing Wnt signaling. However, in
response to altered ROS levels, H2O2 can oxidize Nrx, releasing it from Dvl, and
promoting β-catenin accumulation and subsequent gene activation in the absence of a
Wnt ligand (Funato, Terabayashi et al. 2010).
Another well-characterized branch of the Wnt signaling pathway, the Wnt/planar
cell polarity (PCP) pathway, refers to the polarization of a field of cells within the plane
of a cell sheet. This form of polarization is required for diverse cellular processes in
vertebrates including convergent extension. Studies showed that activation or loss-offunction of PCP pathway components affects various processes in many organisms, such
as ommatidia polarity in the Drosophila compound eye and neuronal polarity in
mammalian neurons (Smith, Conlon et al. 2000). In vertebrates such as X. laevis, this
pathway is involved in regulating gastrulation movements and proper body axis
formation during embryogenesis (Wallingford and Harland 2001).
In the Wnt/PCP pathway, Wnt binds to Fzd thereby activating Dvl, which is
involved in the activation and subsequent phosphorylation of proteins such as Jnk and
Rho, leading to enhanced cell movement. Notably, Dvl is also an important component
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of the Wnt/PCP pathway and is considered a mediator of signaling activation between
these two branches of the Wnt signaling (Axelrod, Miller et al. 1998). Additionally, Nrx
plays a crucial role in the Wnt/PCP pathway through regulation of Dvl (Funato, Michiue
et al. 2008). Overexpression and inhibition of Nrx also disrupts convergent extension
movements that underlie normal gastrulation in X. laevis (Funato, Michiue et al. 2008).
From this data, it is predicted that ROS is a determinant for the activation of the both the
canonical and noncanonical Wnt signaling pathways, and therefore the balance in the
levels of ROS must be tightly regulated during normal embryonic development.

4.1.6 Hypotheses
We have previously shown that overexpression and inhibition of Pex11β is
sufficient and necessary for regulating peroxisome number both in Xenopus laevis A6
kidney epithelial cells and during embryogenesis (Fox, Walsh et al. 2011).

As

peroxisomes may partake in eradication of cellular ROS, we test the hypothesis that
changes to peroxisome number will alter ROS levels. Additionally, we investigate the
effect of changes in ROS levels caused by altered peroxisome number on redox sensitive
Wnt signaling pathways. As we have elucidated an analogous role of Pex11β both in
vivo and in vitro, we first seek to determine how ROS levels change and investigate the
redox-sensitive mechanism of Wnt/PCP in X. laevis A6 cell line, due to the robust
molecular tools available for in vitro research. Our results demonstrated that a decreases
in peroxisome number resulted in increased levels of cellular ROS. This increase in
cellular ROS was associated with changes in noncanonical Wnt/PCP cell signaling. We
therefore propose that peroxisomes are key regulators of cellular ROS levels, highlighting
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their importance to intracellular oxidative balance, which can otherwise perturb the
redox-sensitive Wnt/PCP cell signaling.
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4.2 Materials and Methods
4.2.1 Animal care
Adult X. laevis were reared in accordance with the Canadian Council on Animal
Care regulations. Fertilizations were performed according to Wu and Gerhart (Wu and
Gerhart 1991), and embryos were staged according to Nieuwkoop and Faber
(Nieuwkoop). Embryos to be sectioned were fixed in 4% formaldehyde at desired stages
and paraffin-embedded.

4.2.2

Plasmids and reagents
pRL-TK and pAP1-Luciferase was provided by Dr. Greg Kelly (University of

Western Ontario) and MitoTracker Red (Invitrogen) was generously supplied by Dr.
Robert Cumming (University of Western Ontario). Anti-Dvl, IgG-mouse and anti-Nrx
antibodies were provided by Dr. Greg Kelly (University of Western Ontario).

4.2.3

PCP/pAP1-Luciferase reporter assay
Cells were electroporated with pAP1-Luciferase and pRL-TK to normalize

luciferase levels, plus one of the following as controls and treatments; pcDNA3.1-empty
vector (EV), HA-Pex11β and Pex11β-MO in equal amounts and were prepared 24 hours
post-transfection using the Dual Luciferase Assay Kit as per manufacturer’s instructions
(Promega). Luciferase expression was quantified using the GloMax Multi Detection
System (Promega).
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4.2.4 Microinjection
We previously cloned and sequenced Xenopus full length Pex11β (Fox, Walsh et
al. 2011), and engineered morpholino oligos with Gene Tools (Gene Tools, Philomath,
USA) (Fox, 2012). X. leavis embryos at the one-cell stage were injected with 2.3 nl of
400 μM morpholino (MO) oligos. Each morpholino and Pex11β RNA was used in at
least three independent experiments and injected each time at three different
concentrations (400, 600 and 800 μM).

4.2.5 Transfection and electroporation
A6 cells derived from X. laevis epithelial cells (generous gift from Dr. John
Heikkila, University of Waterloo, ON) were grown in Leibowitz-15 media (with 10%
FBS and 1% penicillin and streptomycin) at room temperature. All transfections were
completed using Neon Transfection System (Invitrogen) performed according to the
manufacturer's protocol with two pulses of 1250 V and 20 ms. GFP was used as a
positive control for transfection efficiency.

Samples were visualized with a Zeiss

AxioStop 2 Mot at the Biotron Institute for Experimental Climate Change Research at the
University of Western Ontario, Canada.

4.2.6

Coimmunoprecipitation
Following treatments, cells were lysed in RIPA buffer and lysates were subject to

coimmunoprecipitation and immunoblotting to determine the interaction between Dvl
and NRX. Cellular lysates (350 ug) were immunoprecipitated with 2.5 ug of anti-Dvl
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antibody (Santa Cruz) overnight at 4°C followed by immunoblot analysis using anti-NRX
(Santa Cruz) as described below.

4.2.7 Immunoblot analysis
JNK (Abcam), phospho-JNK (Abcam), Nrx (Santa Cruz), Dvl (Santa Cruz) and
β-actin (Invitrogen) polyclonal antibodies were used to detect protein from X. laevis A6
cell lysates before and after treatments.

Bradford protein quantifications were used to

ensure that equivalent amounts of protein (10 μg) were loaded for each sample (Bradford
1976). Primary antibodies were used in a 1 in 1000 dilution and secondary 1 in 5,000
dilution, and blots were developed using an enhanced chemiluminescence kit
(Amersham). Band intensities were quantified using Quantity One software (Version
4.4.0 Bio-Rad).

4.2.8 Amplex Red Hydrogen Peroxide/Peroxidase Assay
For the measurement of hydrogen peroxide (H2O2) and peroxidase activity we
used the Amplex Red Hydrogen Peroxide/Peroxidase Assay according to the
manufacturer's instructions (Invitrogen). In the presence of peroxidase, the Amplex Red
reagent reacts with H2O2 in a 1:1 stoichiometry and produces the red-fluorescent
oxidation product, resorufin. Following the respective treatments, A6 cell homogenates
were diluted in reaction buffer and added into 96 well plates. For each well, 50 μL of
working solution of 100 μM Amplex Red reagent and 0.2 U/mL HRP was added and
fluorescence measured after incubation. For H2O2 Assay, a standard curve was generated
from 0 μM to 5 μM and H2O2 concentrations of samples were deduced from the standard
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curve. Resorufin fluorescence was measured with excitation at 530-560 nm and emission
at 590 nm. The data were analyzed by ANOVA, and means were compared by using
Student's t test (P < 0.05).

4.2.9 MitoTracker Red Assay
To measure the degree of mitochondrial ROS production, A6 cells were
transfected with plasmids encoding HA-Pex11β, Pex11β-MO and an empty vector. Cells
were seeded in triplicate, at 3.0 X 105 cells/well in 6 well plates. After 24 hours, media
was replaced with phenol red free L-15 with 200 nm MitoTracker® Red CM-H2XROS
(Invitrogen) and incubated for 20 minutes. After incubation, cells were then washed
twice with PBS, and visualized in phenol red-free media using a fluorescent microscope
(Zeiss AxioObserver, 20X objective). Ten images from randomly selected regions were
taken from each well using a QImaging camera and QCapture Pro Software. The
fluorescent intensity of each image was quantified using Image J software.

4.2.10 Intracellular ROS Assay (DCFDA)
To measure the degree of global ROS production, A6 cells were transfected with
plasmids encoding HA-Pex11β, Pex11β-MO and an empty vector. Cells were seeded in
triplicate, at 3.0 X 105 cells/well in 6 well plates. After 24 hours, media was replaced
with phenol red free L-15 with 400 nm of 5-(and-6)-Carboxy-2’,7-Dichlorofluorescein
Diacetate (DCM-H2DCFDA) (Invitrogen) and incubated for 30 minutes. After
incubation, cells were then washed twice with PBS and visualized with a fluorescent
microscope (Zeiss AxioObserver, 20X objective). Ten images from randomly selected
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regions were taken from each well using a QImaging camera and QCapture Pro
Software. The fluorescent intensity of each image was quantified using Image J
software.

4.2.11 Statistical Analyses
Data from all experiments were representative of three independent biological
replicates performed on separate occasions. Analysis of data between control and treated
or transfected groups was performed using a Student’s t-Test assuming unequal variances
(Excel, Microsoft Corp., Redmond, WA). P values were one-sided and considered
statistically significant at the 0.05 level. Statistical data is presented as the mean ± S.E.
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4.3 Results
4.3.1 Knockdown of Pex11β yields a bent-axis phenotype in X. laevis developing
embryos.
We carried out loss of function analysis with MO against X. laevis Pex11β.
Previously, we were able to show that Pex11β-MO resulted in decreased protein levels of
Pex11β, PMP70, and GFP-SKL containing structures, confirming the integrity of the MO
and, the relationship of Pex11β to peroxisome number. Microinjection of Pex11β-MO
resulted in distinct developmental abnormalities to early gastrulating embryos compared
to uninjected control embryos (Figure 4.1 A versus B). As development proceeds to
stage 35, results yield a distinct bent (black arrow) and double axis (red arrow) phenotype
(Figure 4.1 D and E versus F and G).

As a positive control β-catenin-MO were

microinjected that resulted ventralization of embryos, which are apparent at
developmental stages 35 relative to uninjected embryos (Figure 4.1 D and E versus H and
I).
The percentages of embryonic defects were counted in three separate rounds of
microinjections. Embryos were counted based on partial or complete phenotypic defects,
complete referring to a bent/double axis phenotype and partial defined as slight
developmental abnormality compared normal development fate maps by Nieuwkoop and
Farber (Nieuwkoop 1972). Uninjected embryos revealed that of 66 embryos counted,
less than 8% were defective (Figure 4.1J). Following microinjection of Pex11β-MO, of
101 injected embryos 56% were defective with 50% representing a complete defect
(Figure 4.1J). Lastly, microinjection of β-catenin-MO in 92 embryos resulted in 78%
defective and 59% with complete defects (Figure 4.1K).

The percentage of viable
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uninjected and injected embryos were counted at stage 35. Embryos were considered
dead if development did not progress following stage 35. 80% of uninjected embryos,
<20% Pex11β-MO injected and <23% β-catenin-MO remained alive at stage 35 (Figure
4.1K).
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Figure 4.1. Embryonic knockdown of Pex11β yields a double/bent-axis phenotype in
X. laevis developing embryos.

Microinjection of Pex11β-Morpholino (MO caused

defects to gastrulation at stage 10 (A versus B) and resulted in a double (red arrow) bent
axis (black arrow) to developing embryos at stage 35 (D and E versus F and G). βcatenin-MOs were used as a positive control for our MO study. Microinjecting βcatenin-MOs resulted in ventralization of embryos as anticipated (C, H and I). Defects to
developing embryos were quantified at stage 35. Embryos were counted based on partial
or complete phenotypic defects, complete referring to a bent/double axis phenotype and
partial defined as slight developmental abnormality compared normal development fate
maps by Nieuwkoop and Farber (Nieuwkoop 1972). Of the 66 uninjected embryos <8%
were defective (J).

Following knockdown of Pex11β, 56% of 101 embryos were

defective, with 50% representing a complete defect (J). Microinjecting β-catenin-MO in
92 embryos resulted in 78% defective and 59% with complete defects (J). Embryo
viability was counted at stage 35 for all treatments. Over 80% of uninjected embryos,
<20% Pex11β-MO injected and <23% β-catenin-MO remained alive at stage 35 (K).
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4.3.2 Overexpression and inhibition of Pex11β decreases or increases H2O2 levels,
respectively in X. laevis A6 cells
To determine changes in intracellular H2O2, levels were detected specifically
using an Amplex Red Hydrogen Peroxide/Peroxidase Assay. Overexpression of HAPex11β resulted in a 1.25-fold decrease in H2O2 levels as show by decreases in relative
fluorescence units (RFU) to control EV (vehicle) (Figure 4.2). Overexpression of HACatalase resulted in a 2-fold decrease in H2O2 levels as shown by decreases in RFU to
control (Figure 4.2). Pex11β-MO resulted in a 1.25-fold increased H2O2 levels. HAPMP70 and β-catenin-MO, used as positive controls, released no changes H2O2 levels as
shown by no changes in RFU versus EV (Figure 4.2). Samples were run in triplicate to
determine statistical significances as shown by a single asterisk.
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Figure 4.2. H2O2 levels change in response to Pex11β expression in in X. laevis A6
cells. The levels of H2O2 were determined by measuring changes in resorufin generation
in the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit. Overexpression of Pex11β
and catalase resulted in a 1.25-fold and 2-fold decrease in H2O2 levels compared to empty
vector (EV), respectively. Knockdown of Pex11β resulted in a 1.25-fold increased H2O2
levels compared to EV. Resorufin fluorescence was measured with excitation at 530-560
nm and emission at 590 nm. Data were analyzed by ANOVA, and means were compared
by using Student's t test, P<0.05. Statistical significance indicated by single asterisks,
compared to vehicle.
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4.3.3 Inhibition of Pex11β increases global ROS levels in X. laevis A6 cells
An oxidant signal in response to insulin was demonstrated in 3T3-L1 adipocytes
loaded with CM-H2DCF-DA, a redox indicator dye that is trapped intracellularly after
cleavage by cellular esterases. When oxidized in situ, DCFDA generates a signal that is
visualized by fluorescence microscopy. Following empty vector transfection, a strong
oxidant signal was detected by DCFDA fluorescence as shown in Figure 4.3. We next
determined whether changes in the levels of Pex11β could affect intracellular ROS levels.
While overexpression of Pex11β studies revealed slight decreases in the relative
fluorescence (Figure 4.3B), following electroporation of our Pex11β-MO we detected a
strong fluorescence increase compared to our empty vector and overexpression results
(Figure 4.3C versus A and B). Results were statistically compared in Figure 4.3D, which
highlight a >2.5-fold increase in fluorescence following knockdown of Pex11β.

4.3.4 Inhibition of Pex11β increases mitochondrial ROS levels in X. laevis A6 cells
i next hypothesized that Pex11β expression could have an effect on mitochondrial
ROS levels. In order to visualize mitochondrial ROS levels in A6 cells, we used a cellpermeable low toxicity fluorescent dye, MitoTracker Red CMX-ROS (Invitrogen), which
stains mitochondria specifically and responds to changes in mitochondrial membrane
potential. Following empty vector transfection, a weak MitoTracker Red signal was
detected as shown in Figure 4.4A. i next determined whether changes in the level of
Pex11β could affect mitochondrial ROS. While overexpression studies revealed slight
decreases in the relative fluorescence (Figure 4.4B), consistent with our DCFDA data,
following electroporation of our Pex11β-MO I detected a strong increase in
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mitochondrial ROS compared to that from the empty vector and EV and overexpression
experiments (Figure 4.4C versus A and B). Results were statistically compared in Figure
4.4D, which is highlighted by a >2.5-fold increase following knockdown of Pex11β.

	
  
Figure 4.3.

156
Live cell DCFDA stain reveals increases in global ROS following

inhibition of Pex11β. Endogenous ROS levels were detected in control, empty vector
(EV) (A), with little changes following overexpression of Pex11β (B). Inhibition of
Pex11β revealed increased levels of fluorescence compared to overexpression and EV (A
and B versus C). Quantification of the mean fluorescence intensity generated by the
oxidation of DCFDA was expressed as a percentage of fluorescence from ten randomly
selected cells. A significant increase in fluorescence intensity was found following
knockdown of Pex11β as noted by double asterisks (D). P<0.05. n=25 randomly selected
cells.
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Figure 4.4. Live cell MitoTracker Red stain reveals increases mitochondrial ROS
following inhibition of Pex11β. Mitochondrial ROS production was observed from
control, empty vector (EV), and following overexpression and inhibition of Pex11β in A6
cells. Endogenous mitochondrial ROS levels were detected in control EV (A), with little
change following overexpression of Pex11β (B). Inhibition of Pex11β revealed increased
levels of fluorescence compared to overexpression and EV (A and B versus C).
Quantification of the mean fluorescence intensity generated by the oxidation of
MitoTracker Red was expressed as a percentage of fluorescence from ten randomly
selected cells. A significant increase in fluorescence intensity was found following
knockdown of Pex11β as indicated by double asterisks (D). P<0.05. n=25 randomly
selected cells.
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4.3.5 Inhibition of Pex11β increases Wnt/PCP signaling in X. laevis A6 cells
Since we found that inhibition of Pex11β results in bent/double axis phenotype
during X. laevis development (Figure 4.1) and ROS levels are directly related to the
number of peroxisomes (Figure 4.2, 4.3 and 4.4), then one would predict the
possibility of aberrant cell signaling due to loss of Pex11β. As it was previously
elucidated that Nrx regulates the Wnt/PCP pathway in X. laevis (Funato, Michiue et
al. 2008), we sought to determine if inhibition of Pex11β, resulting in decreased
peroxisome numbers and increases ROS levels, resulted in the activation of the redoxsensitive Wnt/PCP signaling pathway.
We first examined changes in JNK/AP-1 cell signaling using pAP-1-Luciferase
that serves as a reporter for changes in the Wnt/PCP cell singling pathway. Our results
indicate a >4-fold increase in the amount of luciferase detected following inhibition of
Pex11β versus both overexpression and control EV (Figure 4.5). As the current known
downstream effectors of the PCP pathway are Rho-like GTPases and c-Jun terminal
kinase (JNK) kinase, we investigated whether knockdown of Pex11β increases the levels
of JNK and the active forms phospho-JNK. Our results indicate increases in levels of
phospho-JNK following inhibition of Pex11β, suggesting a relationship between
increased ROS and Wnt/PCP cell signaling (Figure 4.6 A and B).
To elucidate whether Nrx negatively regulated Wnt/PCP cell signaling we
performed a coimmunoprecipitation to determine the interaction of Dvl and Nrx, by
immunoprecipitating (IP) with anti-Dvl antibodies, followed by immunoblotting (IB)
using for Nrx. Our results reveal that knockdown of Pex11β, decreased the levels of Nrx
detected compared to both untransfected and GFP transfected cells (Figure 4.7). These
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results suggest that a redox-sensitive mechanism exists for Wnt/PCP cell signaling in X.
laevis A6 cells.
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Figure 4.5. Knockdown of Pex11β increases AP-1 associated cell signaling in X.
laevis A6 cells as evident by a reporter gene expression assay. X. laevis A6 cells were
transfected pRL-TK to normalize luciferase levels and with pAP-1-Luciferase reporter
constructs to monitor the activity of AP-1 regulated signal transduction in response to
inhibition and overexpression of Pex11β. Inhibition of Pex11β resulted in a >4-fold
increase in the levels of luciferase compared to that of overexpression of Pex11β and
empty vector (EV), as quantified using Student T-test between treatments.
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Figure 4.6. Knockdown of Pex11β increases phosphorylated-active-JNK protein
levels. Immunoblot analyses of active (phosphorylated) and inactive forms of JNK were
performed to determine changes relative protein levels. Inhibition of Pex11β resulted in
a >2-fold increase in the relative protein levels of phosphorylated Jnk compared to
Pex11β overexpression and electroporation of EV (A and B).
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Figure 4.7. Immunoprecipitation of Dvl revealed that knockdown of Pex11β
decreases Dvl-Nrx association in X. laevis A6 cells. Immunoprecipitation (IP) with
anti-Dvl followed by immunoblotting (IB) using anti-Nrx following overexpression and
knockdown of Pex11β reveals knockdown of Pex11β decreases Nrx levels versus
untransfected and GFP transfected cells. Empty vector (EV) and GFP transfected cells
were used as positive control. Total cell lysates were loaded under input lane.
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4.4. Discussion
We have previously revealed the pivotal role of Pex11β in regulating peroxisome
number and catalase levels (Fox, Walsh et al. 2011). Overexpression of Pex11β increased
the number of peroxisomes and increased levels of catalase, whereas the knockdown
decreased the number of peroxisomes, while catalase levels remained unchanged. As
catalase is related to ROS elimination, these results lead us to investigate whether a
relationship exists between peroxisome number, ROS levels and ROS induced changes in
cell signaling in X. laevis A6 cells.

4.4.1. Peroxisome numbers contribute to regulation of redox balance
High peroxisomal consumption of O2 has supported the notion that these
ubiquitous organelles play a key role in both the production and scavenging of ROS,
particularly H2O2 (Schrader and Fahimi 2006). Therefore, we first elucidated whether
changes in peroxisome numbers affect cellular levels of H2O2 in A6 cells. We carried out
a fluorogenic assay to quantify the relative levels of H2O2 following overexpression or
knockdown of Pex11β.

We detected a significant decrease in H2O2 following

overexpression of Pex11β, and significant increase in H2O2 following knockdown of
Pex11β, indicating changes in peroxisome number directly affect intracellular levels of
H2O2. A previous study in liver cells revealed that 20-60% of total H2O2 generated inside
of peroxisomes diffuses to the surrounding media (Boveris, Oshino et al. 1972). In
addition, it was demonstrated that H2O2 could rapidly cross the peroxisomal membrane,
likely through the newly identified porin-like channel (Rokka, Antonenkov et al. 2009).
These studies, along with our results, suggest that peroxisomes not only contribute to
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levels of cytosolic H2O2, however, their numbers may also greatly affect the amount of
H2O2 present in surrounding tissue and media.
In addition to H2O2, peroxisomes contain enzymatic sources of membranepermeant superoxide and nitric oxide (Fransen, Nordgren et al. 2011).

Therefore,

peroxisomes are likely a cellular source of various types of ROS. Consequently, we
tested whether peroxisome number has an effect on global ROS levels by measuring ROS
levels within cells. Our results demonstrated that knockdown of Pex11β significantly
increased cellular ROS levels.
To further investigate these peroxisome induced changes in ROS, we next
examined the relationship between Pex11β and mitochondrial ROS.

Similar to

peroxisomes, mitochondria have the ability to adapt in number in response to metabolic
cues, and there is evidence suggesting these two organelles may cooperate via cross talk
(Schrader and Yoon 2007). In addition, it has become clear that the relationship between
peroxisomes and mitochondria is redox-sensitive (Fransen, Nordgren et al. 2011).
Recently, it was found that cells lacking catalase or functional peroxisomes resulted in
mitochondrial redox imbalance (Ivashchenko, Van Veldhoven et al. 2011).

We

investigated whether changes to peroxisome number could result in redox changes that
are communicated to the mitochondria. Consistent with our previous findings on global
ROS levels, we demonstrated that knockdown of Pex11β decreased peroxisome number,
and significantly increased the levels of mitochondrial ROS. In summary, these findings
suggest that peroxisome-derived oxidative stress may trigger signaling/communication
events that ultimately result in increased levels of H2O2, as well as changes in the global
levels of ROS that directly induce mitochondrial stress. This altered redox state can have
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varying cellular consequences, and can particularly effect ROS sensitive cell signaling
pathways.

4.4.2. Peroxisome generated ROS mediates cell signaling
It is well known that ROS can modulate the activity of redox sensitive proteins.
The intracellular localization and activity of numerous proteins may be, directly or
indirectly, controlled by the oxidation of thiol groups on redox-sensitive cysteine residues.
Peroxisomes have intricate protective mechanisms to counteract oxidative stress and
maintain redox balance. An imbalance in ROS levels may damage biomolecules and
perturb cellular thiol levels, resulting in deregulation of cellular signaling pathways.
Thus, the levels of peroxisome generated ROS must be tightly regulated, as certain levels
of ROS may act as regulators of intracellular signaling (Masters 1996).
Of the many signaling molecules that are ROS sensitive, we investigated the Wnt
signaling pathways, as Wnt is an important mediator of normal development. The redox
sensitivity of Wnt/β-catenin and Wnt/PCP cell signaling were first elucidated during X.
laevis embryogenesis (Funato, Michiue et al. 2006; Funato, Michiue et al. 2008; Funato
and Miki 2010). Nrx is a redox-sensitive protein that can negatively regulate both Wnt
pathways through inhibition of Dvl. When oxidized, Nrx detaches from Dvl, thereby
activating each pathway in the absence of their respective ligands.

We show that

knockdown of Pex11β during X. laevis embryogenesis resulted in a bent-axis phenotype
that is typically observed in embryos with abnormal PCP activation (Sokol 1996;
Wallingford and Harland 2001). Additionally, a similar phenotype is also observed
following redox-sensitive activation of Wnt/PCP cell signaling (Funato, Michiue et al.
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2008).
Using mouse intestinal cells, it was shown that Wnt treatment induces the
production of ROS through NADPH oxidase (Nox1), thereby increasing levels of
cytosolic H2O2, oxidizing Nrx and activating Wnt/β-catenin signaling (Kajla, Mondol et
al. 2012).

On the basis of this data and our current results, we hypothesized that

knockdown of Pex11β would result in redox-sensitive activation of Wnt/PCP cell
signaling in X. laevis A6 cells. Our research verifies the recently published X. laevis
embryonic work mentioned above (Kajla, Mondol et al. 2012).

We examined the

activation of Wnt/PCP cell signaling by pAP-1-luciferase reporter gene expression assays,
and following inhibition of Pex11β demonstrated a significant increase in Wnt/PCP cell
signaling. Additionally, we saw increases in the amount of active (phosphorylated) Jnk, a
downstream target of the Wnt/PCP pathway. To corroborate this, we also found through
immunoprecipitation analyses that knockdown of Pex11β reduced the interaction
between Dvl and Nrx. Therefore, consistent with previous X. laevis embryo studies on
redox-sensitive Wnt signaling, we highlight the importance of peroxisome produced ROS
as secondary messengers in X. laevis cells (Figure 4.8).

4.2.3. Concluding remarks
Taken together, these results suggest that peroxisomes are key elements in
maintaining oxidative balance.

Perturbation to the number of peroxisomes can

independently affect intracellular ROS levels, damaging various cellular constituents;
thus, their numbers must be tightly regulated. Additionally, our studies have extended
the current understanding of the redox-sensitive mechanism of Wnt/PCP cell signaling.
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It will be interesting to further investigate the mechanisms through which changes in
peroxisome number may alter cell signaling.
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Figure 4.8. Schematic model of redox-sensitive Wnt/PCP activation in X. laevis
A6 cells following Pex11β inhibition.

1) Knockdown of Pex11β, decreasing

peroxisome number, results in significant increases in H2O2, global ROS and 2)
mitochondrial ROS levels. 3) Increases in ROS resulted in the oxidation of Nrx, 4)
liberating Nrx from Dvl thereby activating Wnt/PCP cell signaling 5) resulting in the
phosphorylation and subsequent activation of Jnk, 6) leading to changes in cell
polarity and cytoskeletal rearrangements.

	
  

174

Frizzled"

S

4"
Nrx"

Dvl"

S
H2O2"

H2O2"

Rho"

Rac"

Rock"

Jnk"

O2-!

H2O2"
O2-!
H2O2"

3"

O2-!

P"
O2-!

H2O2"
O2-!

H2O2"
Mitochondria"

2"

5"

6"

H2O2"

Pex11β-MO"

O2-!

O2-!

H2O2"
O2-!

c-Jun"
AP-1"
Nucleus"

H2O2"

Pex11β-MO" 1"

Peroxisome"
H2O2"

O2-!
O2-!

O2-!
H2O2"

H2O2"

© Mark A. Fox

H2O2"
Peroxisome"

	
  

175

4.5. References
Antonenkov, V. D., S. Grunau, et al. (2010). "Peroxisomes are oxidative organelles."
Antioxid Redox Signal 13(4): 525-537.
Axelrod, J. D., J. R. Miller, et al. (1998). "Differential recruitment of Dishevelled
provides signaling specificity in the planar cell polarity and Wingless
signaling pathways." Genes Dev 12(16): 2610-2622.
Bienert, G. P., J. K. Schjoerring, et al. (2006). "Membrane transport of hydrogen
peroxide." Biochim Biophys Acta 1758(8): 994-1003.
Bonekamp, N. A., A. Volkl, et al. (2009). "Reactive oxygen species and
peroxisomes: struggling for balance." Biofactors 35(4): 346-355.
Boveris, A., N. Oshino, et al. (1972). "The cellular production of hydrogen
peroxide." Biochemical Journal 128(3): 617-630.
Bradford, M. M. (1976). "A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye
binding." Anal Biochem 72: 248-254.
Clevers, H. (2006). "Wnt/beta-catenin signaling in development and disease." Cell
127(3): 469-480.
Fox, M. A., L. A. Walsh, et al. (2011). "PEX11beta induces peroxisomal gene
expression and alters peroxisome number during early Xenopus laevis
development." BMC Dev Biol 11: 24.
Fransen, M., M. Nordgren, et al. (2011). "Role of peroxisomes in ROS/RNSmetabolism: Implications for human disease." Biochim Biophys Acta.
Funato, Y., T. Michiue, et al. (2006). "The thioredoxin-related redox-regulating
protein nucleoredoxin inhibits Wnt-beta-catenin signalling through
dishevelled." Nat Cell Biol 8(5): 501-508.
Funato, Y., T. Michiue, et al. (2008). "Nucleoredoxin regulates the Wnt/planar cell
polarity pathway in Xenopus." Genes Cells 13(9): 965-975.
Funato, Y. and H. Miki (2010). "Redox regulation of Wnt signalling via
nucleoredoxin." Free Radic Res 44(4): 379-388.
Funato, Y., T. Terabayashi, et al. (2010). "Nucleoredoxin sustains Wnt/beta-catenin
signaling by retaining a pool of inactive dishevelled protein." Curr Biol
20(21): 1945-1952.
Goth, L. and J. W. Eaton (2000). "Hereditary catalase deficiencies and increased risk
of diabetes." Lancet 356(9244): 1820-1821.
Ivashchenko, O., P. P. Van Veldhoven, et al. (2011). "Intraperoxisomal redox
balance in mammalian cells: oxidative stress and interorganellar cross-talk."
Mol Biol Cell 22(9): 1440-1451.
Kajla, S., A. S. Mondol, et al. (2012). "A crucial role for Nox 1 in redox-dependent
regulation of Wnt-beta-catenin signaling." FASEB J.
Krysko, O., L. Hulshagen, et al. (2007). "Neocortical and cerebellar developmental
abnormalities in conditions of selective elimination of peroxisomes from
brain or from liver." Journal of Neuroscience Research 85(1): 58-72.
Legakis, J. E., J. I. Koepke, et al. (2002). "Peroxisome senescence in human
fibroblasts." Mol Biol Cell 13(12): 4243-4255.

	
  

176

Masters, C. J. (1996). "Cellular signalling: the role of the peroxisome." Cellular
Signalling 8(3): 197-208.
Muller, M. (2009). "Cellular senescence: molecular mechanisms, in vivo significance,
Rokka,and redox considerations." Antioxid Redox Signal 11(1): 59-98.
Niethammer, P., C. Grabher, et al. (2009). "A tissue-scale gradient of hydrogen
peroxide mediates rapid wound detection in zebrafish." Nature 459(7249):
996-999.
Nieuwkoop, P. D. (1973). "The organization center of the amphibian embryo: its
origin, spatial organization, and morphogenetic action." Adv Morphog 10: 139.
Paulsen, C. E. and K. S. Carroll (2010). "Orchestrating redox signaling networks
through regulatory cysteine switches." ACS Chem Biol 5(1): 47-62.
Rokka, A., V. D. Antonenkov, et al. (2009). "Pxmp2 is a channel-forming protein in
Mammalian peroxisomal membrane." PLoS One 4(4): e5090.
Schrader, M. and H. D. Fahimi (2006). "Peroxisomes and oxidative stress." Biochim
Biophys Acta 1763(12): 1755-1766.
Schrader, M. and Y. Yoon (2007). "Mitochondria and peroxisomes: are the 'big
brother' and the 'little sister' closer than assumed?" Bioessays 29(11): 11051114.
Sokol, S. Y. (1996). "Analysis of Dishevelled signalling pathways during Xenopus
development." Curr Biol 6(11): 1456-1467.
Wallingford, J. B. and R. M. Harland (2001). "Xenopus Dishevelled signaling
regulates both neural and mesodermal convergent extension: parallel forces
elongating the body axis." Development 128(13): 2581-2592.
Wu, M. and J. Gerhart (1991). "Raising Xenopus in the laboratory." Methods Cell
Biol 36: 3-18.

	
  

177

CHAPTER 5
CONCLUSIONS AND GENERAL DISCUSSION
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5.1. Summary and Conclusions
By examining peroxisomes during X. laevis embryogenesis and in X. laevis A6
cells, I have shown for the first time that changes to peroxisome numbers directly effect
the levels of ROS, which subsequently result in altercations to redox-sensitive Wnt/PCP
cell signaling. As the physiological roles of peroxisomes are well characterized, however,
the functionality of these organelles in terms of biogenesis and division, is less
established. In addition to understanding how peroxisomes contribute to normal cellular
functioning, the importance of also understanding how peroxisome division is regulated
is highlighted by a group of fatal human diseases termed peroxisome biogenesis disorders
(PBD). Patients with PBDs have either a lack of, or very small numbers of functional
peroxisomes, which results in a neurological abnormalities (Weller, Gould et al. 2003).
Studies characterizing the mechanisms underlying peroxisome division, suggest that
various peroxins are involved in governing organelle numbers, and that the cell signals
regulating overall numbers may be linked to metabolism (Yan, Rayapuram et al. 2005).
One model for division suggests that Pex11β interacts with a translipid bilayer on the
luminal side of the peroxisomal membrane, inducing peroxisome elongation (Platta and
Erdmann 2007). Once the organelle membrane has elongated, which signals membrane
division, various peroxins and dynamin-related proteins facilitate membrane constriction
and fission. Pex11β and other peroxins have been implicated in membrane elongation,
although few have been demonstrated to induce peroxisome division via overexpression
analyses, thereby increasing peroxisome numbers in the absence of extracellular stimuli
(Li and Gould 2002). To my knowledge, there has been no mechanistic link between
Pex11β, peroxisome number and cellular ROS levels. Over the past decades it was
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revealed that peroxisomes participate not only in the generation of ROS, which can
negatively affect cell fate and result in malignant degeneration, but also in cell rescue
from the damaging effects of such radicals (Schrader and Fahimi 2006). High levels of
ROS exert a toxic effect on biomolecules such as DNA, proteins, and lipids, leading to
the accumulation of oxidative damage in diverse cellular locations. The accumulation of
ROS may contribute to the deregulation of redox-sensitive metabolic and signalling
pathways, and to various pathological conditions including cancers, diabetes and
neurodegeneration. Due to their oxidative metabolism, peroxisomes are considered a
source of oxidative stress. However, peroxisomes can also respond to ROS that have
been generated in other intracellular or extracellular locations, indicating that they likely
also play a role in protecting the cell against oxidative damage. I altered the amount of
ROS in A6 cells through overexpression and knockdown of Pex11β, which resulted in an
increase or decrease in the number of peroxisomes, respectively. Along with the notion
that peroxisomes adapt in number due to changes in metabolic load, my results shed light
on the possibility that perhaps peroxisome numbers are a reflection of the cellular
oxidation state. This illustrates the importance of these organelles in regulating oxidative
stress, suggesting that peroxisomes may behave as signaling compartments through
redox-orchestrated cell-signaling events.
During X. laevis development, Wnt/PCP cell signaling regulates the convergent
extension movements that underlie normal gastrulation.

Disruption of Wnt/PCP

signaling during X. laevis development causes convergent extension errors, resulting in
defects in gastrulation and a bent-axis phenotype in later developmental stages
(Wallingford and Harland 2001).

Following knockdown of Pex11β during

	
  

180

embryogenesis, I observed a bent/double-axis phenotype in developing embryos,
suggesting that changes in peroxisome number may lead to altercations in Wnt/PCP cell
signaling. Indeed, using X. laevis A6 cells, I have confirmed that there is a link between
peroxisome number and Wnt/PCP signaling. I have previously demonstrated that altered
levels of Pex11β can affect the numbers of peroxisomes and cellular ROS levels, and I
also investigated whether a redox-sensitive mechanism for Wnt/PCP cell signaling exists
in A6 cells. My results indicate that altered ROS levels, which occur as a result of
changes to peroxisome number induced by knockdown of Pex11β, resulted in increased
Wnt/PCP cell signaling. This study sheds light on the possibility that peroxisomes, along
with their well-established physiological functions, are intricate organelles involved in
the maintenance of intracellular oxidative balance.

5.2. Contributions to the Current Knowledge of Peroxisome Division
The current understanding is that peroxisome divisions require several steps,
namely i) the induction of proliferation, ii) elongation of the organelle, iii) constriction
and membrane fission and iv) maturation of the newly formed organelle by matrix and
membrane protein import. Of the many proteins implicated in this process, the first
identified to be crucial for peroxisome division was Pex11, classified in Saccharomyces
cerevisiae (Erdmann, Veenhuis et al. 1989). Moreover, Pex11 is the most abundant
component of the peroxisomal membrane, and is an integral membrane protein
containing two transmembrane spans, with both termini facing the cytosol (Abe,
Okumoto et al. 1998; Lorenz, Maier et al. 1998).

The importance of Pex11 in

peroxisome division is emphasized by its imperative role in initiating elongation of the
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organelle membrane, a required step in the divisionary process (Huber, Koch et al. 2011).
In S. cerevisiae, deletion of the Pex11 gene led to the occurrence of fewer and
enlarged peroxisomes, whereas overexpression of Pex11 resulted in increased numbers of
these organelles (Erdmann and Blobel 1995). Homologues of S. cerevisiae-Pex11 are
known in most eukaryotic organisms and these usually contain more than one Pex11
protein (Marshall, Krimkevich et al. 1995). Depending on the species, up to three
members of the Pex11 family were identified in yeasts, plants typically contain five,
whereas vertebrates harbor three, namely Pex11α, Pex11β and Pex11γ. While the
functions of Pex11 proteins have been well characterized in mammals, no current data
exits on the role of this family of peroxisomal proteins in other vertebrates.
Previous studies have suggested that there is a metabolic regulation of peroxisome
division. Chang et al. (1999) found that defects in peroxisomal fatty acid β-oxidation
enzymes reduced peroxisome abundance in mammalian cells. These results suggested
that the recruitment of Pex11 to the peroxisomal membrane, and the induction of
membrane elongation, was in fact linked to metabolism. More recently, Pex11β was
found to drive peroxisome division in the absence of peroxisome metabolism, and that
the loss of mammalian Pex11β causes a reduction in peroxisome abundance in the
absence of peroxisomal metabolic substrates (Li and Gould 2002). As a result, it was
proposed that Pex11β has a direct role in peroxisome division, and that loss of Pex11β
inhibits peroxisome metabolism indirectly, perhaps due to altered membrane structure or
dynamics.
No current data is available on the role of Pex11 proteins in vertebrate
development, and it is unknown whether peroxisomes exist in fertilized eggs or in early
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stage vertebrate embryos. It is for these reasons that I have attempted to elucidate the
molecular mechanisms of Pex11β during X. laevis embryogenesis and in A6 cells. This
study has revealed for the first time when functional peroxisomes are first formed during
embryogenesis, and has demonstrated that overexpression or knockdown of Pex11β
during this fragile time can induce an early- or late-onset to peroxisome biogenesis,
respectively.

These results confirm that Pex11β not only partakes in membrane

elongation to induce the divisionary process, it also suggests that Pex11β has a functional
role in de novo biogenesis. If the onset of Pex11β expression during embryogenesis
serves as a molecular switch to induce peroxisome biogenesis, other peroxisomal
components should modulate their expression patterns accordingly. To corroborate this, I
have also demonstrated that alterations to the levels of Pex11β, both in vitro and in vivo,
directly affect the levels of expression of peroxisomal genes and proteins that encode
peroxisomal cytosolic chaperones, membrane proteins, ATPases, membrane recruitment
factors and antioxidant enzymes found within the organelle itself. Additionally, I found
that the expression pattern for PPAR-γ was either decreased or increased following
overexpression or inhibition of Pex11β, respectively, both in vitro and in vivo.
Collectively, these studies suggest for the first time that Pex11β can modulate
peroxisome number and may be involved in the de novo biogenesis pathway.

5.3. Contributions to the Current Knowledge of Peroxisomes and Oxidative Stress
The current knowledge on the relationship between peroxisomes and ROS is
centred on the high peroxisomal consumption of O2, the subsequent large production of
ROS byproducts, and the discovery of several ROS metabolizing oxidative enzymes
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found within these organelles. These facts alone support the notion that these ubiquitous
organelles play a key role in both the production and scavenging of ROS in the cell, in
particular H2O2 (Fransen, Nordgren et al. 2011).

The main metabolic processes

contributing to the generation of H2O2 in peroxisomes are the β-oxidation of fatty acids
and the disproportionation of superoxide radicals. It is obvious that due to their oxidative
metabolism, peroxisomes are considered a source of oxidative stress.

However,

peroxisomes can also respond to oxidative stress and ROS, which have been generated in
other intra- or extracellular locations, most likely to protect the cell against oxidative
damage.
An interesting feature of peroxisomes is their ability to proliferate and multiply,
or be degraded in response to nutritional and environmental stimuli (Fransen, Nordgren et
al. 2011). In mammalian cells for example, the number and size of peroxisomes as well
as the expression of peroxisomal β-oxidation enzymes are increased substantially when
activators of PPARs are applied (Fahimi, Reinicke et al. 1982). Such conditions are
considered to generate peroxisome-induced oxidative stress, which may overwhelm the
antioxidant capacity and lead to disease.

These studies suggest that if peroxisome

number can adapt to certain cellular conditions, then changes to their numbers could
mediate changes to the cellular oxidative environment; a concept I examined in my
research.
When elucidating the molecular mechanisms of Pex11β, I performed various
fluorogenic experiments to determine whether changes in peroxisome numbers affected
ROS levels in A6 cells. I have shown that Pex11β inhibition, resulted in decreased
peroxisome numbers and increased levels of H2O2, as well as increased levels of global
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and mitochondrial ROS. Through my overexpression and inhibition analyses of Pex11β,
I have demonstrated that a dynamic relationship exists between the levels of Pex11β and
catalase expression. Interestingly, overexpression of Pex11β significantly increased both
the relative gene and protein levels of catalase.

Immunohistochemical analysis for

catalase revealed increases in punctate-like structures, which are indicative of
peroxisomes, consistent with previous overexpression analyses for Pex11β in human
fibroblast cells (Li, Baumgart et al. 2002). However, inhibition of Pex11β resulted in no
significant increase or decrease in catalase expression or the appearance of localized
structures in A6 cells.
Along with catalase levels, overexpression of Pex11β significantly increased the
levels of Pex5, a cytosolic receptor for PTS1-like proteins such as catalase (Freitas,
Francisco et al. 2011). Inhibition of Pex11β revealed no changes in Pex5 levels, however,
it did result in significant decreases in Pex1 – an ATPase involved in the energy
dependent steps of matrix protein import. Thus, induction of the divisionary process
through Pex11β overexpression, increases the number of pre-peroxisomal vesicles that
mature through matrix and membrane protein import. Perhaps knockdown of Pex11β
results in membrane defects, creating nonfunctional “giant” peroxisomes, a common
phenotype in yeast that occurs when peroxisomes are unable to segregate (Erdmann and
Blobel 1995). Therefore, in the absence of Pex11β peroxisome division may begin,
however, without proper elongation machinery, matrix protein import is halted, and
peroxisomes become nonfunctional. This could explain why I observed decreased levels
of Pex1 following inhibition of Pex11β, while Pex5 levels remained unchanged.
Consequently, I have determined that the decreased numbers of functional peroxisomes,
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following Pex11β inhibition, resulted in significant increases in ROS levels.

5.4. Contributions to the Current Knowledge on Redox-sensitive Wnt signaling
Our current understanding of redox-regulated Wnt signaling is based on the
results of several experiments conducted using X. laevis embryos. Both the canonical
Wnt/β-catenin and noncanonical Wnt/PCP pathways have been reported as redoxsensitive through the negative regulation of Nrx, a thioredoxin-related protein. Upon
oxidation, Nrx is liberated from Dvl, resulting in the activation of Wnt signaling in the
absence of the Wnt ligand. The redox mechanisms of Wnt signaling was extensively
studied through the canonical signaling pathway (Funato and Miki 2010), and it has been
suggested that the same mechanisms apply to noncanonical Wnt/PCP signaling (Funato,
Michiue et al. 2008). In X. laevis embryos, Funato et al., (2008) found that knockdown
of Nrx yields a bent-axis phenotype that is typically observed in embryos with abnormal
Wnt/PCP cell signaling (Funato, Michiue et al. 2008). Additionally, Nrx overexpression
can inhibit Dvl-induced phosphorylation of c-Jun terminal kinase (Jnk), a downstream
component of the noncanonical Wnt/PCP cell-signaling pathway (Funato, Michiue et al.
2008). Conclusively, these data suggest that redox-regulated Wnt signaling functions
through the canonical and noncanonical Wnt/PCP pathways.
More recently, a study investigating ROS, Wnt and Nrx, revealed that superoxidegenerating NADPH oxidase1 (Nox1) is involved in the redox sensitive mechanisms of
Wnt signaling (Kajla, Mondol et al. 2012). It was demonstrated in mouse epithelial cells
that treatment with a Wnt ligand, activating canonical Wnt signaling, consequently
increases ROS levels through active Nox1. Increases in ROS resulted in the oxidation
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and inactivation of Nrx, thereby releasing Nrx from Dvl and activating Wnt/β-catenin
cell signaling.
Since knockdown of Pex11β resulted in a bent/double-axis in X. laevis embryos,
similar to the phenotype observed following abnormal activation of Wnt/PCP cell
signaling, I investigated whether increases in ROS via knockdown of Pex11β, could
independently activate Wnt/PCP signaling. My data suggests that increases in ROS, by
Pex11β knockdown, can induce Wnt/PCP cell signaling through redox-sensitive
liberation of Nrx. In addition to this, I have also shown that this activation induces the
phosphorylation of Jnk, increasing the activity of this pathway. Collectively, I have
revealed both the importance of peroxisome numbers to the cellular oxidation state and
shed light on the redox-sensitive mechanisms of Wnt/PCP cell signaling in X. laevis A6
cells.

5.5. Limitations of Research and Suggestions for Future Studies
5.5.1. Pex11β induces peroxisomal gene expression and alters peroxisome number
during early Xenopus laevis development.
Although I have shown for the first time a in vivo the link between Pex11β and
peroxisome division in vertebrates, the major limitation of this study is the lack of
evidence supporting the idea that Pex11β overexpression is inducing the formation of
fully functional mature peroxisomes.

As mentioned previously, co-overexpression

studies in Xenopus embryos and A6 cells with Pex11β and GFP-SKL, resulted in
increases in GFP-containing bodies suggestive of functional peroxisomes. In order for
PTS1-type cargoes (GFP-SKL) to be imported into the peroxisomal matrix, all
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components of the importomer must be present. These data presented in this study
suggest they are present. However, identifying the functionalities of these organelles, for
example in terms of their ability to chain shorten VLCFA, and synthesize
etherphospholipids such as plasmalogen and cholesterol, would shed insight as to
whether or not these GFP-SLK containing bodies are functional mature peroxisomes. In
future experiments, measuring levels of these metabolic substrates would increase the
veracity of this study. Additionally, I also believe using a Pex11β-GFP fusion protein
would confirm the ability of Pex11β to induce peroxisomal elongation, and demonstrate
the formation of tubular peroxisomal membrane compartments.

Together, these

additional experiments would lead to a more complete understanding of the mechanism
of Pex11 β induced peroxisome division that was proposed earlier.

5.5.2. Morpholino-induced knockdown of Xenopus laevis Pex11-Beta reveals its pivotal
role in peroxisome biogenesis during embryonic development
As these experiments recapitulate my previous studies, using knockdown, I first
suggest examining the levels of metabolic byproducts of peroxisomes. This data will
shed light on the role of Pex11β, in its ability to reduce the number of functional mature
organelles. Another possible improvement to my in vivo studies relates to whether or not
knockdown of Pex11β interrupts the de novo formation of peroxisomes. The specific
experiment discussed in this study examined the localization patterns of GFP-SKL
following knockdown of Pex11β in early embryos.

Interestingly, the fluorescence

staining of GFP-SKL was much different from the typical punctate-like structures
representative of peroxisomes. Rather, I observed irregularly shaped GFP-like structures
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after knockdown of Pex11β. These data, in corroboration with the overexpression of
Pex11β in embryos, suggest that Pex11β may interfere with de novo biogenesis in
embryos.

The staining pattern observed is suggestive of lager structures possibly

representing “blebs” of ER, which peroxisomes utilize for de novo biogenesis.

To

examine this further, I would propose confirming the role of Pex11β expression on the
formation of functional peroxisomes and their relationship to the ER.

In these

experiments I would use peroxisomal markers (GFP-SKL) in combination with ERspecific fluorescent stains to determine the association between these two organelles, and
examine how fluorescence patterns change based on Pex11β expression. Although there
would be many experiments needed to confirm these findings, especially in vivo, I have
still revealed a novel mechanism for Pex11β during embryonic development.

5.5.3. Peroxisome numbers directly affect levels of ROS and the redox-sensitive
mechanism of Wnt signaling
The results of this study give insight as to how the numbers of peroxisomes affect
intracellular ROS levels, and suggest that changes in ROS resulting from modulations in
peroxisome number may induce the redox-sensitive activation of Wnt/PCP cell signaling
pathway. As a result, I have established that peroxisomes are important regulators of
oxidative stress. To further investigate how ROS levels fluctuate based on Pex11β
expression, in future experiments I would examine the relative gene expression of
antioxidants housed in peroxisomes, mitochondria and the cytosol. In combination with
this study, I would investigate the protein expression of antioxidants, such as
peroxiredoxin, via 2D-PAGE, to visualize changes in oxidation state. Once again, these
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results would give insight on changes in ROS levels resulting from Pex11β expression.
The most intriguing part of my study indicates that changes in the levels of ROS via
knockdown of Pex11β, result in irregular Wnt/PCP cell signaling.

In addition to the

experiments I have already performed, in order to confirm the redox-sensitivity
association of Nrx and Dvl, I would recapitulate my coimmunoprecipitation studies using
both oxidizing and reducing agents in A6 cells. This would verify that, along with
changes in peroxisome number, exogenous oxidants would have a similar effect on the
interaction between these two proteins.
Although this study may serve as the basis for many different areas of future
research, recapitulating these experiments during X. laevis development will highlight an
important avenue of investigation in our lab. I would propose looking at the interaction
of Nrx and Dvl by first overexpression and inhibition of Pex11β, and then through
microinjection of oxidizing and reducing agents in Xenopus embryos. Next, I would
determine if I could rescue the bent/double-axis phenotype caused by knockdown of
Pex11β, by co-microinjection Pex11β-MO and Nrx into early developing embryos.
Again, these studies would act as a series of pilot experiments that will be continued in
our lab as they offer great potential for increasing our understanding of the dynamic
relationship between Pex11β, peroxisome number, ROS levels and the mechanisms
behind redox-sensitive Wnt/PCP signaling during X. leaves embryogenesis.
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Appendix A: Additional Data
Figure A.1. Embryonic inhibition of Pex11β increased PPARγ levels during early X.
laevis embryogenesis. The respective mRNA levels represent measures of mid-log
phase RT-PCR product band intensities, relative to levels of EF1α. RT-PCR analysis of
RNA isolated from control stage 10 embryos and Pex11β-MO injected embryos revealed
significant changes in the expression of PPARγ, but not PPARα, and PPARδ. PPARα
levels were decreased by treatment. P<0.05, n=3. Values presented are the means ± SE.
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Figure A.2. Overexpression of Pex11β decreases peroxidase activity in X. laevis A6
cells. Peroxidase activity were determined by measuring changes in resorufin generation
in the Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit. Overexpression of Pex11β
and catalase resulted in a 1.25-fold and 2-fold decrease peroxidase activity compared to
EV, respectively. Resorufin fluorescence was measured with excitation at 530-560 nm
and emission at 590 nm. Data were analyzed by ANOVA, and means were compared by
using Student's t test.

RFU (530nm/560nm)

Peroxidase Activity Assay
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Figure A.3. Comicroinjection of Pex11β and Pex11β-MO rescues PMP70 and
Catalase protein levels during X. laevis embryogenesis.

Western blot analysis

revealed comicroinjection Pex11β and Pex11β-MO rescues protein levels during
embryogenesis.

Catalase protein levels reveal slight increases following Pex11β,

however now changes were found after injection of GFP, Pex11β-MO, while
comicroinjection of Pex11β and Pex11β-MO reveal levels similar to GFP (A). PMP
protein levels reveal increases following Pex11β, decreases following Pex11β-MO, while
comicroinjection of Pex11β and Pex11β-MO reveal levels similar to GFP (A). Protein
loading in each lane was confirmed and standardized via a β-actin antibody (A). Western
blot signals were digitized and data were quantified and analyzed (B), comicroinjection
indications that protein levels are rescued to their endogenous levels.
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Figure A.4. Comicroinjection of Pex11β and Pex11β-MO rescues peroxisome related
gene levels during X. laevis embryogenesis. RT-PCR analysis during normal
embryogenesis revealed that the levels of all genes exampled increased as development
progressed from stage 15 to 30, both following injection of GFP and comicroinjection of
Pex11β and Pex11β-MO. Following comicroinjection of Pex11β and Pex11β-MO, band
intensities of RT-PCR products were unchanged compared to that of GFP control injected
embryos.

The respective bar heights represent measures of mid-log phase RT-PCR

products band intensities relative to the levels of EF1α.
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Appendix B:
Xenopus laevis developmental stages 1 and 2

Adapted and modified from Nieuwkoop and Faber 1956.
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Xenopus laevis developmental stages 10 and 15.

Adapted and modified from Nieuwkoop and Faber 1956.
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Xenopus laevis developmental stages 20.

Adapted and modified from Nieuwkoop and Faber 1956.
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Xenopus laevis developmental stage 30.

Adapted and modified from Nieuwkoop and Faber 1956.
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Xenopus laevis developmental stage 45.

Adapted and modified from Nieuwkoop and Faber 1956.
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Appendix C:

AUP Number: 2009-044 PI Name: Damjanovski, SashkoAUP Title: MMP Activation
During Xenopus Development
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2009-044 has been approved.
1. This AUP number must be indicated when ordering animals for this project.
2. Animals for other projects may not be ordered under this AUP number.
3. Purchases of animals other than through this system must be cleared through the
ACVS office.Health certificates will be required.
REQUIREMENTS/COMMENTS Please ensure that individual(s) performing
procedures on live animals, as described in this protocol, are familiar with the contents of
this document.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety
components (biosafety, radiation safety, general laboratory safety) comply with
institutional safety standards and have received all necessary approvals. Please consult
directly with your institutional safety officers.
Submitted by: Thompson, Sharla H on behalf of the Animal Use Subcommittee
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